Vitamin	O
D3-	O
and	O
retinoic	O
acid-induced	O
monocytic	O
differentiation	O
:	O
interactions	O
between	O
the	O
endogenous	B-protein
vitamin	I-protein
D3	I-protein
receptor	I-protein
,	O
retinoic	B-protein
acid	I-protein
receptors	I-protein
,	O
and	O
retinoid	B-protein
X	I-protein
receptors	I-protein
in	O
U-937	B-cell_line
cells	I-cell_line
.	O

Retinoic	O
acid	O
(	O
RA	O
)	O
and	O
1	O
,	O
25	O
alpha-dihydroxycholecalciferol	O
(	O
VitD3	O
)	O
are	O
potent	O
regulators	O
of	O
hematopoletic	O
differentiation	O
.	O

Yet	O
,	O
little	O
is	O
known	O
as	O
to	O
how	O
the	O
RA	B-protein
and	I-protein
VitD3	I-protein
receptor	I-protein
network	I-protein
operates	O
in	O
hematopoietic	B-cell_type
cells	I-cell_type
,	O
and	O
whether	O
receptor	O
interactions	O
can	O
explain	O
the	O
interplay	O
between	O
the	O
RA	O
-and	O
VitD3-signaling	O
pathways	O
during	O
differentiation	O
.	O

Therefore	O
,	O
we	O
analyzed	O
the	O
expression	O
,	O
DNA	O
binding	O
,	O
and	O
transcriptional	O
activity	O
of	O
the	O
endogenous	B-protein
RA	I-protein
and	I-protein
VitD3	I-protein
receptors	I-protein
[	O
retinoic	B-protein
acid	I-protein
receptors	I-protein
(	O
RARs	B-protein
)	O
,	O
retinoid	B-protein
X	I-protein
receptors	I-protein
(	O
RXRs	B-protein
)	O
,	O
and	O
VitD3	B-protein
receptor	I-protein
(	O
VDR	B-protein
)	O
]	O
in	O
the	O
U-937	B-cell_line
cell	I-cell_line
line	I-cell_line
,	O
in	O
which	O
RA	O
and	O
VitD3	O
induce	O
distinct	O
monocytic	O
differentiation	O
pathways	O
.	O

VitD3	O
induction	O
resulted	O
in	O
the	O
formation	O
of	O
VDR/RXR	B-protein
DNA-binding	I-protein
complexes	I-protein
on	O
both	O
VitD3	B-DNA
response	I-DNA
elements	I-DNA
and	O
RA	B-DNA
response	I-DNA
elements	I-DNA
(	O
RAREs	B-DNA
)	O
.	O

However	O
,	O
transcriptional	O
activation	O
was	O
only	O
observed	O
from	O
a	O
VitD3	B-DNA
response	I-DNA
element-driven	I-DNA
reporter	I-DNA
construct	I-DNA
.	O

Several	O
DNA-binding	B-protein
complexes	I-protein
were	O
detected	O
on	O
RAREs	B-DNA
in	O
undifferentiated	B-cell_type
cells	I-cell_type
.	O

Stimulation	O
by	O
RA	O
resulted	O
in	O
increased	O
RAR	B-protein
beta	I-protein
/RXR	B-protein
DNA	O
binding	O
,	O
activated	O
RARE	B-DNA
-dependent	O
transcription	O
,	O
and	O
increased	O
expression	O
of	O
RAR-beta	B-protein
.	O

Concomitant	O
stimulation	O
by	O
VitD3	O
inhibited	O
the	O
RA-stimulated	O
formation	O
of	O
RAR	B-protein
beta/RXR	I-protein
heterodimers	I-protein
,	O
favoring	O
VDR	B-protein
/RXR	B-protein
binding	O
to	O
the	O
RARE	B-DNA
.	O

Also	O
,	O
VitD3	O
inhibited	O
the	O
expression	O
of	O
CD23	B-protein
and	O
CD49f	B-protein
,	O
characteristic	O
markers	O
of	O
retinoid-induced	O
U-937	B-cell_line
cell	I-cell_line
differentiation	O
.	O

In	O
contrast	O
,	O
neither	O
the	O
RA-stimulated	O
,	O
RARE	B-DNA
-mediated	O
transcription	O
nor	O
the	O
induced	O
RAR-beta	B-protein
expression	O
was	O
suppressed	O
by	O
VitD3	O
,	O
suggesting	O
that	O
VitD3	O
selectively	O
inhibited	O
the	O
retinoid-induced	O
differentiation	O
program	O
but	O
not	O
the	O
RARE	B-DNA
-mediated	O
signal	O
.	O

These	O
results	O
demonstrate	O
a	O
complex	O
role	O
for	O
VitD3	O
in	O
modifying	O
the	O
retinoid	O
differentiation	O
pathway	O
and	O
may	O
have	O
implications	O
for	O
differentiation-inducing	O
therapy	O
of	O
hematopoietic	O
tumors	O
.	O

Vol	NULL
.	NULL

7	NULL
,	NULL
1239-1249	NULL
,	NULL
September	NULL
1996	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
Vitamin	NULL
D3-	NULL
and	NULL
Retinoic	NULL
Acid-induced	NULL
Monocytic	NULL
Differen-tiation	NULL
:	NULL
Interactions	NULL
between	NULL
the	NULL
Endogenous	NULL
Vitamin	NULL
D3	NULL
Receptor	NULL
,	NULL
Retinoic	NULL
Acid	NULL
Receptors	NULL
,	NULL
and	NULL
Retinoid	NULL
X	NULL
Receptors	NULL
in	NULL
U-937	NULL
Cells	NULL
'	NULL
Johan	NULL
Botling	NULL
,	NULL
Fredrik	NULL
ﬁbers	NULL
,	NULL
Hans	NULL
Torma	NULL
,	NULL
Pentti	NULL
Tuohimaa	NULL
,	NULL
Merja	NULL
Blauer	NULL
,	NULL
and	NULL
Kenneth	NULL
Nilsson*	NULL
Laboratory	NULL
of	NULL
Tumor	NULL
Biology	NULL
,	NULL
Department	NULL
of	NULL
Pathology	NULL
[	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
F.	NULL
O.	NULL
,	NULL
K.	NULL
N.JJ	NULL
,	NULL
and	NULL
Department	NULL
of	NULL
Dermatology	NULL
[	NULL
H.	NULL
T.	NULL
]	NULL
,	NULL
Uppsala	NULL
University	NULL
,	NULL
$	NULL
-751	NULL
85	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
,	NULL
and	NULL
Department	NULL
of	NULL
Anatomy	NULL
,	NULL
University	NULL
of	NULL
Tampere	NULL
Medical	NULL
School	NULL
,	NULL
33100	NULL
Tampere	NULL
,	NULL
Fintand	NULL
[	NULL
P.	NULL
T.	NULL
,	NULL
M	NULL
.	NULL

B	NULL
.	NULL
]	NULL

Abstract	NULL
Retinoic	NULL
acid	NULL
(	NULL
RA	NULL
)	NULL
and	NULL
1,25	NULL
«	NULL
-dihydroxycholecalciferol	NULL
(	NULL
VitD3	NULL
)	NULL
are	NULL
potent	NULL
regulators	NULL
of	NULL
hematopoietic	NULL
differentiation	NULL
.	NULL

Yet	NULL
,	NULL
little	NULL
is	NULL
known	NULL
as	NULL
to	NULL
how	NULL
the	NULL
RA	NULL
and	NULL
VitD3	NULL
receptor	NULL
network	NULL
operates	NULL
in	NULL
hematopoietic	NULL
cells	NULL
,	NULL
and	NULL
whether	NULL
receptor	NULL
interactions	NULL
can	NULL
explain	NULL
the	NULL
interplay	NULL
between	NULL
the	NULL
RA-	NULL
and	NULL
VitD3-signaling	NULL
pathways	NULL
during	NULL
differentiation	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
expression	NULL
,	NULL
DNA	NULL
binding	NULL
,	NULL
and	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
endogenous	NULL
RA	NULL
and	NULL
VitD3	NULL
receptors	NULL
[	NULL
retinoic	NULL
acid	NULL
receptors	NULL
(	NULL
RARs	NULL
)	NULL
,	NULL
retinoid	NULL
X	NULL
receptors	NULL
(	NULL
RXRs	NULL
)	NULL
,	NULL
and	NULL
VitD3	NULL
receptor	NULL
(	NULL
VDR	NULL
)	NULL
]	NULL
in	NULL
the	NULL
U-937	NULL
cell	NULL
line	NULL
,	NULL
in	NULL
which	NULL
RA	NULL
and	NULL
VitD3	NULL
induce	NULL
distinct	NULL
monocytic	NULL
differentiation	NULL
pathways	NULL
.	NULL

VitD3	NULL
induction	NULL
resulted	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
VDR/RXR	NULL
DNA-binding	NULL
complexes	NULL
on	NULL
both	NULL
VitD3	NULL
response	NULL
elements	NULL
and	NULL
RA	NULL
response	NULL
elements	NULL
(	NULL
RAREs	NULL
)	NULL
.	NULL

However	NULL
,	NULL
transcriptional	NULL
activation	NULL
was	NULL
only	NULL
observed	NULL
from	NULL
a	NULL
VitD3	NULL
response	NULL
element-driven	NULL
reporter	NULL
construct	NULL
.	NULL

Several	NULL
DNA-binding	NULL
complexes	NULL
were	NULL
detected	NULL
on	NULL
RAREs	NULL
in	NULL
undifferentiated	NULL
cells..	NULL
Stimulation	NULL
by	NULL
RA	NULL
resulted	NULL
in	NULL
increased	NULL
RARGB/RXR	NULL
DNA	NULL
binding	NULL
,	NULL
activated	NULL
RARE-dependent	NULL
transcription	NULL
,	NULL
and	NULL
increased	NULL
expression	NULL
of	NULL
RAR-B	NULL
.	NULL

Concomitant	NULL
,	NULL
stimulation	NULL
by	NULL
VitD3	NULL
inhibited	NULL
the	NULL
RA-stimulated	NULL
formation	NULL
of	NULL
RARB/RXR	NULL
heterodimers	NULL
,	NULL
favoring	NULL
VDR/	NULL
RXR	NULL
binding	NULL
to	NULL
the	NULL
RARE	NULL
.	NULL

Also	NULL
,	NULL
VitD3	NULL
inhibited	NULL
the	NULL
expression	NULL
of	NULL
CD23	NULL
and	NULL
CD49f	NULL
,	NULL
characteristic	NULL
markers	NULL
of	NULL
retinoid-induced	NULL
U-937	NULL
cell	NULL
differentiation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
neither	NULL
the	NULL
RA-stimulated	NULL
,	NULL
RARE-mediated	NULL
transcription	NULL
nor	NULL
the	NULL
induced	NULL
RAR-B	NULL
expression	NULL
was	NULL
suppressed	NULL
by	NULL
VitD3	NULL
,	NULL
suggesting	NULL
that	NULL
VitD3	NULL
selectively	NULL
Received	NULL
3/22/96	NULL
;	NULL
revised	NULL
6/3/96	NULL
;	NULL
accepted	NULL
6/28/96	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Swedish	NULL
Cancer	NULL
Society	NULL
,	NULL
the	NULL
Hans	NULL
von	NULL
Kantzow	NULL
Foundation	NULL
,	NULL
and	NULL
the	NULL
Crown	NULL
Princess	NULL
Lovisa	NULL
Foundation	NULL
.	NULL

2	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Phone	NULL
:	NULL
46-18663823	NULL
;	NULL
Fax	NULL
:	NULL
46-18558931	NULL
;	NULL
E-mail	NULL
:	NULL
Kenneth.Nilsson	NULL
@	NULL
patologi	NULL
.	NULL

uu.se	NULL
.	NULL

inhibited	NULL
the	NULL
retinoid-induced	NULL
differentiation	NULL
program	NULL
but	NULL
not	NULL
the	NULL
RARE-mediated	NULL
signal	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
a	NULL
complex	NULL
role	NULL
for	NULL
VitD3	NULL
in	NULL
modifying	NULL
the	NULL
retinoid	NULL
differentiation	NULL
pathway	NULL
and	NULL
may	NULL
have	NULL
implications	NULL
for	NULL
differentiation-inducing	NULL
therapy	NULL
of	NULL
hematopoietic	NULL
tumors	NULL
.	NULL

Introduction	NULL
The	NULL
growth	NULL
and	NULL
differentiation	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
tissues	NULL
are	NULL
regulated	NULL
by	NULL
the	NULL
hormone-like	NULL
vitamin	NULL
A	NULL
and	NULL
D	NULL
metabolites	NULL
RA®	NULL
and	NULL
VitD3	NULL
.	NULL

In	NULL
the	NULL
hematopoietic	NULL
system	NULL
,	NULL
RA	NULL
promotes	NULL
differentiation	NULL
of	NULL
myeloid	NULL
precursor	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
,	NULL
and	NULL
the	NULL
RARs	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
stem	NULL
cell	NULL
growth	NULL
and	NULL
lineage	NULL
commitment	NULL
(	NULL
2	NULL
)	NULL
.	NULL

In	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
,	NULL
the	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
chromosomal	NULL
translocation	NULL
of	NULL
the	NULL
RAR-	NULL
«	NULL
gene	NULL
results	NULL
in	NULL
a	NULL
block	NULL
in	NULL
differentiation	NULL
,	NULL
which	NULL
can	NULL
be	NULL
abrogated	NULL
by	NULL
RA	NULL
treatment	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
patients	NULL
(	NULL
3	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
its	NULL
effects	NULL
on	NULL
myeloid	NULL
differentiation	NULL
,	NULL
VitD3	NULL
has	NULL
been	NULL
noted	NULL
to	NULL
have	NULL
potent	NULL
immunomodulatory	NULL
effects	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Several	NULL
leukemia	NULL
and	NULL
lymphoma	NULL
cell	NULL
lines	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
differentiate	NULL
in	NULL
vitro	NULL
by	NULL
RA	NULL
and	NULL
VitD3	NULL
and	NULL
have	NULL
been	NULL
extensively	NULL
used	NULL
as	NULL
models	NULL
for	NULL
studies	NULL
of	NULL
differentiation-associ-ated	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
and	NULL
growth	NULL
arrest	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

RA	NULL
and	NULL
VitD3	NULL
exert	NULL
their	NULL
biological	NULL
effects	NULL
through	NULL
a	NULL
family	NULL
of	NULL
the	NULL
nuclear	NULL
steroid	NULL
receptors	NULL
:	NULL
VDR	NULL
;	NULL
RAR-	NULL
«	NULL
,	NULL
-B	NULL
,	NULL
and	NULL
-y	NULL
,	NULL
which	NULL
are	NULL
activated	NULL
by	NULL
at-RA	NULL
and	NULL
9cis-RA	NULL
;	NULL
and	NULL
RXR-	NULL
«	NULL
,	NULL
-B	NULL
,	NULL
and	NULL
-y	NULL
,	NULL
which	NULL
bind	NULL
9cis-RA	NULL
(	NULL
7	NULL
)	NULL
.	NULL

The	NULL
receptors	NULL
form	NULL
dimers	NULL
and	NULL
act	NULL
as	NULL
transcription	NULL
factors	NULL
on	NULL
cognate	NULL
promoter	NULL
response	NULL
elements	NULL
composed	NULL
of	NULL
direct	NULL
repeats	NULL
of	NULL
the	NULL
consensus	NULL
half-site	NULL
AGGTCA	NULL
organized	NULL
in	NULL
tandem	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
response	NULL
element	NULL
specificity	NULL
is	NULL
mainly	NULL
determined	NULL
by	NULL
the	NULL
number	NULL
of	NULL
spacer	NULL
nucleotides	NULL
between	NULL
the	NULL
half	NULL
sites	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
DR	NULL
spaced	NULL
by	NULL
three	NULL
nucleotides	NULL
(	NULL
DR-3	NULL
)	NULL
constitutes	NULL
a	NULL
VDRE	NULL
,	NULL
whereas	NULL
DR-2	NULL
and	NULL
DR-5	NULL
are	NULL
RAREs	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

The	NULL
RXRs	NULL
serve	NULL
as	NULL
common	NULL
cofactors	NULL
in	NULL
VitD3	NULL
and	NULL
RA	NULL
signaling	NULL
(	NULL
11	NULL
)	NULL
and	NULL
preferentially	NULL
bind	NULL
the	NULL
5	NULL
'	NULL
half-site	NULL
,	NULL
whereas	NULL
the	NULL
VDR	NULL
and	NULL
RARs	NULL
occupy	NULL
the	NULL
downstream	NULL
half-site	NULL
on	NULL
their	NULL
respective	NULL
response	NULL
elements	NULL
(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
complexity	NULL
of	NULL
RA	NULL
and	NULL
VitD3	NULL
signaling	NULL
at	NULL
the	NULL
receptor	NULL
level	NULL
is	NULL
increased	NULL
further	NULL
by	NULL
additional	NULL
receptor	NULL
complexes	NULL
that	NULL
do	NULL
not	NULL
use	NULL
RXR	NULL
as	NULL
a	NULL
cofactor	NULL
.	NULL

°	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
RA	NULL
,	NULL
retinoic	NULL
acid	NULL
;	NULL
VitD3	NULL
,	NULL
1,25	NULL
«	NULL
-dihydroxy-cholecalciferol	NULL
;	NULL
RAR	NULL
,	NULL
retinoic	NULL
acid	NULL
receptor	NULL
,	NULL
RXR	NULL
,	NULL
retinoid	NULL
X	NULL
receptor	NULL
;	NULL
VDR	NULL
,	NULL
VitD3	NULL
receptor	NULL
;	NULL
DR	NULL
,	NULL
direct	NULL
repeat	NULL
;	NULL
RARE	NULL
,	NULL
RA	NULL
response	NULL
element	NULL
;	NULL
VDRE	NULL
,	NULL
VitD3	NULL
response	NULL
elements	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
at-RA	NULL
,	NULL
all-frans-RA	NULL
;	NULL
PRD1	NULL
,	NULL
positive	NULL
regulatory	NULL
domain	NULL
|	NULL
in	NULL
the	NULL
B	NULL
,	NULL
-interferon	NULL
promoter	NULL
;	NULL
B-RARE	NULL
,	NULL
RAR-B	NULL
,	NULL
promoter	NULL
RARE	NULL
;	NULL
OC-VDRE	NULL
,	NULL
VDRE	NULL
from	NULL
the	NULL
osteocalcin	NULL
gene	NULL
promoter	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyitransferase	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
CMV	NULL
,	NULL
cytomegalovirus	NULL
.	NULL

1240	NULL
-	NULL
VDR	NULL
,	NULL
RAR	NULL
,	NULL
and	NULL
RXR	NULL
Interactions	NULL
in	NULL
U-937	NULL
Cells	NULL
For	NULL
example	NULL
,	NULL
both	NULL
RAR	NULL
and	NULL
VDR	NULL
can	NULL
homodimerize	NULL
or	NULL
interact	NULL
with	NULL
each	NULL
other	NULL
as	NULL
RAR/~VDR	NULL
heterodimers	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
RAR	NULL
and	NULL
VDR	NULL
can	NULL
form	NULL
heterodimers	NULL
with	NULL
the	NULL
thyroid	NULL
hormone	NULL
receptor	NULL
and	NULL
so-called	NULL
``	NULL
orphan	NULL
receptors	NULL
``	NULL
such	NULL
as	NULL
the	NULL
chicken	NULL
ovalbumin	NULL
upstream	NULL
promoter	NULL
transcription	NULL
factor	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
published	NULL
effects	NULL
of	NULL
stimulation	NULL
with	NULL
at-RA	NULL
,	NULL
cis-RA	NULL
,	NULL
and	NULL
VitD3	NULL
,	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
,	NULL
on	NULL
the	NULL
DNA-binding	NULL
and	NULL
transcriptional	NULL
activity	NULL
of	NULL
some	NULL
of	NULL
these	NULL
receptor	NULL
complexes	NULL
are	NULL
divergent	NULL
(	NULL
13	NULL
,	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
most	NULL
of	NULL
the	NULL
data	NULL
on	NULL
RAR	NULL
,	NULL
VDR	NULL
,	NULL
and	NULL
RXR	NULL
activity	NULL
derive	NULL
from	NULL
experiments	NULL
on	NULL
purified	NULL
or	NULL
overexpressed	NULL
receptors	NULL
and	NULL
remain	NULL
to	NULL
be	NULL
confirmed	NULL
in	NULL
native	NULL
cells	NULL
and	NULL
tissues	NULL
.	NULL

Only	NULL
a	NULL
few	NULL
reports	NULL
have	NULL
been	NULL
published	NULL
on	NULL
the	NULL
DNA-binding	NULL
and	NULL
transcriptional	NULL
activity	NULL
of	NULL
endogenous	NULL
nuclear	NULL
receptors	NULL
expressed	NULL
at	NULL
low	NULL
numbers	NULL
in	NULL
cells	NULL
,	NULL
and	NULL
these	NULL
studies	NULL
have	NULL
mainly	NULL
been	NULL
performed	NULL
in	NULL
nonhematopoietic	NULL
cells	NULL
.	NULL

In	NULL
view	NULL
of	NULL
the	NULL
important	NULL
regulatory	NULL
effects	NULL
of	NULL
RA	NULL
and	NULL
VitD3	NULL
during	NULL
hematopoietic	NULL
development	NULL
and	NULL
the	NULL
therapeutic	NULL
potential	NULL
of	NULL
these	NULL
drugs	NULL
,	NULL
we	NULL
set	NULL
out	NULL
to	NULL
investigate	NULL
the	NULL
early	NULL
RA	NULL
and	NULL
VitD3	NULL
response	NULL
during	NULL
induced	NULL
monocytic	NULL
differentiation	NULL
.	NULL

The	NULL
U-937	NULL
histiocytic	NULL
lymphoma	NULL
cell	NULL
line	NULL
is	NULL
a	NULL
model	NULL
for	NULL
human	NULL
monoblast-to-macrophage	NULL
differentiation	NULL
(	NULL
5	NULL
,	NULL
19	NULL
)	NULL
.	NULL

RA	NULL
and	NULL
VitD3	NULL
induce	NULL
terminal	NULL
monocytic	NULL
differentiation	NULL
and	NULL
growth	NULL
arrest	NULL
in	NULL
this	NULL
system	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Parallel	NULL
to	NULL
their	NULL
common	NULL
effects	NULL
on	NULL
U-937	NULL
cell	NULL
maturation	NULL
,	NULL
RA-	NULL
and	NULL
VitD3-specific	NULL
differentiation	NULL
pathways	NULL
are	NULL
suggested	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
unique	NULL
morphological	NULL
characteristics	NULL
and	NULL
distinct	NULL
patterns	NULL
of	NULL
antigen	NULL
expression	NULL
,	NULL
as	NULL
asserted	NULL
by	NULL
differential	NULL
regulation	NULL
of	NULL
the	NULL
CD14	NULL
,	NULL
CD23	NULL
,	NULL
and	NULL
CD49f	NULL
genes	NULL
,	NULL
are	NULL
induced	NULL
by	NULL
the	NULL
two	NULL
agents	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
,	NULL
U-937	NULL
cells	NULL
resemble	NULL
the	NULL
HL-60	NULL
cell	NULL
line	NULL
,	NULL
in	NULL
which	NULL
RA	NULL
and	NULL
VitD3	NULL
promote	NULL
differentiation	NULL
along	NULL
two	NULL
different	NULL
lineages	NULL
,	NULL
the	NULL
granulocytic	NULL
and	NULL
monocytic	NULL
pathways	NULL
,	NULL
respectively	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
partly	NULL
unique	NULL
and	NULL
partly	NULL
overlapping	NULL
effects	NULL
of	NULL
RA	NULL
and	NULL
VitD3	NULL
on	NULL
myeloid	NULL
differentiation	NULL
make	NULL
these	NULL
cell	NULL
lines	NULL
interesting	NULL
models	NULL
for	NULL
studies	NULL
of	NULL
the	NULL
basic	NULL
RA	NULL
and	NULL
VitD3	NULL
response	NULL
through	NULL
their	NULL
respective	NULL
receptors	NULL
.	NULL

In	NULL
this	NULL
article	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
the	NULL
expression	NULL
and	NULL
activity	NULL
of	NULL
the	NULL
endogenous	NULL
VDR	NULL
,	NULL
RARs	NULL
,	NULL
and	NULL
RXRs	NULL
in	NULL
U-937	NULL
cells	NULL
during	NULL
induced	NULL
differentiation	NULL
.	NULL

Previously	NULL
characterized	NULL
RAREs	NULL
and	NULL
VDREs	NULL
were	NULL
used	NULL
in	NULL
EMSAs	NULL
and	NULL
in	NULL
reporter	NULL
gene	NULL
constructs	NULL
to	NULL
study	NULL
the	NULL
DNA-binding	NULL
and	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
receptors	NULL
after	NULL
VitD3	NULL
and	NULL
RA	NULL
stimulation	NULL
.	NULL

The	NULL
objective	NULL
was	NULL
to	NULL
characterize	NULL
the	NULL
early	NULL
differentiation	NULL
signals	NULL
elicited	NULL
by	NULL
RA	NULL
and	NULL
VitD3	NULL
and	NULL
to	NULL
relate	NULL
these	NULL
results	NULL
to	NULL
the	NULL
specific	NULL
biological	NULL
responses	NULL
that	NULL
these	NULL
agents	NULL
induce	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

Results	NULL
Expression	NULL
of	NULL
VDR	NULL
,	NULL
RARs	NULL
,	NULL
and	NULL
RXRs	NULL
during	NULL
Differentiation	NULL
of	NULL
U-937	NULL
Cells	NULL
.	NULL

We	NULL
first	NULL
analyzed	NULL
the	NULL
expression	NULL
of	NULL
VDR	NULL
and	NULL
retinoid	NULL
receptors	NULL
in	NULL
U-937	NULL
cells	NULL
induced	NULL
to	NULL
differentiate	NULL
by	NULL
VitD3	NULL
,	NULL
at-RA	NULL
,	NULL
9cis-RA	NULL
,	NULL
or	NULL
phorbol	NULL
esters	NULL
(	NULL
PMA	NULL
)	NULL
.	NULL

The	NULL
mRNA	NULL
expression	NULL
of	NULL
the	NULL
various	NULL
receptors	NULL
after	NULL
72	NULL
h	NULL
of	NULL
induced	NULL
differentiation	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Unstimulated	NULL
cells	NULL
expressed	NULL
the	NULL
VDR	NULL
mRNA	NULL
,	NULL
three	NULL
RAR-a	NULL
transcripts	NULL
,	NULL
and	NULL
low	NULL
levels	NULL
of	NULL
RXR-	NULL
«	NULL
and	NULL
RXR-8	NULL
.	NULL

After	NULL
VitD3	NULL
stimulation	NULL
,	NULL
the	NULL
VDR	NULL
and	NULL
RAR-	NULL
«	NULL
expression	NULL
persisted	NULL
,	NULL
and	NULL
the	NULL
RXR-	NULL
«	NULL
and	NULL
-B	NULL
<	NULL
C	NULL
o	NULL
<	NULL
&	NULL
C	NULL
8	NULL
t	NULL
&	NULL
>	NULL
T	NULL
-O	NULL
VDR	NULL
RARa	NULL
RARB	NULL
RXRa	NULL
RXRB	NULL
actin	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

-	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
RA	NULL
and	NULL
VitD3	NULL
receptors	NULL
.	NULL

U-937	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
72	NULL
h	NULL
with	NULL
PMA	NULL
(	NULL
10	NULL
ny	NULL
)	NULL
,	NULL
VitD3	NULL
(	NULL
0.1	NULL
um	NULL
)	NULL
,	NULL
at-RA	NULL
(	NULL
1.0	NULL
um	NULL
)	NULL
,	NULL
and	NULL
9cis-RA	NULL
(	NULL
1.0	NULL
um	NULL
)	NULL
.	NULL

Polyadenylated	NULL
RNA	NULL
was	NULL
prepared	NULL
,	NULL
and	NULL
5	NULL
ug	NULL
were	NULL
fractionated	NULL
on	NULL
a	NULL
gel	NULL
and	NULL
blotted	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
filter	NULL
.	NULL

The	NULL
filter	NULL
was	NULL
sequentially	NULL
hybridized	NULL
to	NULL
°°P-labeled	NULL
fragments	NULL
prepared	NULL
from	NULL
the	NULL
receptor	NULL
cDNAs	NULL
as	NULL
indicated	NULL
and	NULL
reprobed	NULL
with	NULL
«	NULL
-actin	NULL
as	NULL
a	NULL
loading	NULL
control	NULL
.	NULL

The	NULL
sizes	NULL
of	NULL
the	NULL
mRNA	NULL
transcripts	NULL
were	NULL
calculated	NULL
by	NULL
their	NULL
positions	NULL
in	NULL
relation	NULL
to	NULL
the	NULL
18	NULL
S	NULL
and	NULL
28	NULL
S	NULL
rRNAs	NULL
.	NULL

unstim	NULL
,	NULL
unstimulated	NULL
.	NULL

levels	NULL
were	NULL
somewhat	NULL
increased	NULL
.	NULL

Treatment	NULL
with	NULL
at-RA	NULL
or	NULL
9cis-RA	NULL
strongly	NULL
induced	NULL
the	NULL
expression	NULL
of	NULL
RAR-B	NULL
.	NULL

No	NULL
RAR-B	NULL
mRNA	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
VitD3-	NULL
or	NULL
PMA-stimu-lated	NULL
cells	NULL
.	NULL

The	NULL
retinoids	NULL
,	NULL
especially	NULL
9cis-RA	NULL
,	NULL
also	NULL
up-regulated	NULL
RXR-	NULL
«	NULL
expression	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
at-RA	NULL
slightly	NULL
suppressed	NULL
VDR	NULL
expression	NULL
,	NULL
and	NULL
9cis-RA	NULL
treatment	NULL
resulted	NULL
in	NULL
increased	NULL
amounts	NULL
of	NULL
the	NULL
largest	NULL
RAR-a	NULL
«	NULL
transcript	NULL
.	NULL

The	NULL
PMA	NULL
lane	NULL
was	NULL
loaded	NULL
with	NULL
slightly	NULL
less	NULL
RNA	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
a	NULL
weaker	NULL
actin	NULL
signal	NULL
.	NULL

This	NULL
could	NULL
explain	NULL
the	NULL
apparently	NULL
low	NULL
levels	NULL
of	NULL
RXR-	NULL
«	NULL
and	NULL
-B	NULL
in	NULL
this	NULL
lane	NULL
and	NULL
might	NULL
also	NULL
indicate	NULL
that	NULL
PMA	NULL
slightly	NULL
increases	NULL
the	NULL
expression	NULL
of	NULL
VDR	NULL
and	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
A	NULL
OC-VDRE*	NULL
OC-VDRE*	NULL
C	NULL
OC-VDRE*	NULL
€	NULL
vitb3	NULL
72h	NULL
,	NULL
vitbs	NULL
[	NULL
#	NULL
n	NULL
'	NULL
#	NULL
a	NULL
.	NULL

>	NULL
AF	NULL
3	NULL
ne	NULL
pI	NULL
I	NULL
S	NULL
ocNB	NULL
Pag	NULL
Eat	NULL
Paves	NULL
E	NULL
E	NULL
E	NULL
5	NULL
e	NULL
E	NULL
F	NULL
>	NULL
C	NULL
CG	NULL
C	NULL
E	NULL
o	NULL
£	NULL
%	NULL
s	NULL
s	NULL
s	NULL
8	NULL
12	NULL
o	NULL
7	NULL
%	NULL
10+	NULL
+	NULL
F	NULL
%	NULL
2	NULL
2	NULL
g	NULL
3	NULL
>	NULL
3	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11121314	NULL
1	NULL
VDR/RXR	NULL
2	NULL
3	NULL
4	NULL
5	NULL
1	NULL
2	NULL
3	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

VitD3-induced	NULL
OC-VDRE	NULL
DNA	NULL
binding	NULL
.	NULL

Radiolabeled	NULL
OC-VDRE	NULL
oligonucleotides	NULL
were	NULL
mixed	NULL
with	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
unstimulated	NULL
U-937	NULL
cells	NULL
(	NULL
unstim	NULL
)	NULL
or	NULL
from	NULL
cells	NULL
stimulated	NULL
with	NULL
VitD3	NULL
(	NULL
0.1	NULL
um	NULL
)	NULL
.	NULL

The	NULL
complexes	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
excess	NULL
of	NULL
free	NULL
labeled	NULL
oligonucleotide	NULL
was	NULL
run	NULL
out	NULL
of	NULL
the	NULL
gels	NULL
.	NULL

A	NULL
,	NULL
EMSA	NULL
on	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
cells	NULL
incubated	NULL
for	NULL
72	NULL
h	NULL
with	NULL
or	NULL
without	NULL
VitD3	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
protein-DNA	NULL
interactions	NULL
was	NULL
analyzed	NULL
by	NULL
addition	NULL
of	NULL
cold	NULL
OC-VDRE	NULL
,	NULL
DR-3	NULL
,	NULL
B-RARE	NULL
,	NULL
and	NULL
PRD	NULL
!	NULL

oligonucleotides	NULL
as	NULL
indicated	NULL
in	NULL
a	NULL
10-	NULL
,	NULL
50-	NULL
,	NULL
and	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
°°P-labeled	NULL
OC-VDRE	NULL
.	NULL

A	NULL
VitD3-induced	NULL
specific	NULL
OC-VDORE	NULL
DNA-binding	NULL
complex	NULL
(	NULL
arrow	NULL
)	NULL
was	NULL
competed	NULL
by	NULL
cold	NULL
OC-VDRE	NULL
(	NULL
Lanes	NULL
3-5	NULL
)	NULL
and	NULL
related	NULL
response	NULL
elements	NULL
,	NULL
but	NULL
not	NULL
by	NULL
the	NULL
unrelated	NULL
PRD	NULL
!	NULL

sequence	NULL
from	NULL
the	NULL
B	NULL
,	NULL
-IFN	NULL
promoter	NULL
(	NULL
Lanes	NULL
12-14	NULL
)	NULL
.	NULL

B	NULL
,	NULL
EMSA	NULL
on	NULL
a	NULL
nuclear	NULL
extract	NULL
prepared	NULL
from	NULL
U-937	NULL
cells	NULL
stimulated	NULL
with	NULL
VitD3	NULL
for	NULL
72	NULL
h.	NULL
Supershift	NULL
performed	NULL
with	NULL
antibodies	NULL
directed	NULL
to	NULL
the	NULL
VDR	NULL
{	NULL
aVDR	NULL
)	NULL
,	NULL
RAR-a	NULL
(	NULL
aRARa	NULL
)	NULL
,	NULL
RAR-8	NULL
(	NULL
«	NULL
RARB	NULL
)	NULL
and	NULL
the	NULL
RXRs	NULL
(	NULL
«	NULL
RXR	NULL
)	NULL
.	NULL

The	NULL
VitD3-induced	NULL
OC-VDRE	NULL
binding	NULL
complex	NULL
(	NULL
arrow	NULL
)	NULL
was	NULL
supershifted	NULL
by	NULL
VDR	NULL
and	NULL
RXR	NULL
antibodies	NULL
(	NULL
*	NULL
)	NULL
.	NULL

C	NULL
,	NULL
ligand-dependent	NULL
binding	NULL
of	NULL
VDR/RXR	NULL
to	NULL
the	NULL
OC-VDRE	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
unstimulated	NULL
cells	NULL
(	NULL
unstim	NULL
;	NULL
Lane	NULL
1	NULL
)	NULL
and	NULL
VitD3	NULL
treated	NULL
cells	NULL
(	NULL
Lane	NULL
2	NULL
)	NULL
after	NULL
incubation	NULL
for	NULL
4	NULL
h.	NULL
VitD3	NULL
in	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.1	NULL
mm	NULL
was	NULL
added	NULL
to	NULL
a	NULL
binding	NULL
reaction	NULL
containing	NULL
nuclear	NULL
extract	NULL
from	NULL
unstimulated	NULL
cells	NULL
.	NULL

This	NULL
binding	NULL
reaction	NULL
was	NULL
loaded	NULL
in	NULL
Lane	NULL
3	NULL
{	NULL
unstim+	NULL
(	NULL
VitD3	NULL
)	NULL
]	NULL
.	NULL

Arrow	NULL
,	NULL
VDR/RXR	NULL
complex	NULL
formed	NULL
on	NULL
the	NULL
OC-VDRE	NULL
in	NULL
Lanes	NULL
2	NULL
and	NULL
3	NULL
.	NULL

The	NULL
band	NULL
at	NULL
the	NULL
top	NULL
of	NULL
the	NULL
gel	NULL
represents	NULL
AP-1-binding	NULL
activity	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

This	NULL
AP-1	NULL
band	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
harvested	NULL
at	NULL
early	NULL
time	NULL
points	NULL
after	NULL
the	NULL
experiment	NULL
setup	NULL
and	NULL
is	NULL
probably	NULL
a	NULL
result	NULL
of	NULL
serum	NULL
stimulation	NULL
after	NULL
addition	NULL
of	NULL
fresh	NULL
culture	NULL
medium	NULL
to	NULL
the	NULL
cells	NULL
.	NULL

RAR-a	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
receptors	NULL
for	NULL
VitD3	NULL
and	NULL
RA	NULL
are	NULL
expressed	NULL
in	NULL
U-937	NULL
cells	NULL
throughout	NULL
the	NULL
various	NULL
differentiation	NULL
pathways	NULL
.	NULL

VitD3-dependent	NULL
Binding	NULL
of	NULL
Endogenous	NULL
VDR/RXR	NULL
Complexes	NULL
to	NULL
VDREs	NULL
.	NULL

Several	NULL
regulatory	NULL
complexes	NULL
containing	NULL
the	NULL
VDR	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
VDREs	NULL
in	NULL
gene	NULL
promoters	NULL
.	NULL

Experiments	NULL
with	NULL
overexpressed	NULL
or	NULL
purified	NULL
receptors	NULL
have	NULL
shown	NULL
that	NULL
VDRE	NULL
activity	NULL
can	NULL
be	NULL
regulated	NULL
by	NULL
VDR	NULL
homodimers	NULL
and	NULL
by	NULL
VDR	NULL
heterodimerized	NULL
to	NULL
RXR	NULL
,	NULL
RAR	NULL
,	NULL
thyroid	NULL
hormone	NULL
receptor	NULL
,	NULL
or	NULL
chicken	NULL
ovalbumin	NULL
upstream	NULL
promoter	NULL
transcription	NULL
factor	NULL
(	NULL
13-16	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
known	NULL
how	NULL
VDREs	NULL
are	NULL
activated	NULL
during	NULL
induced	NULL
monocytic	NULL
differentiation	NULL
in	NULL
intact	NULL
cells	NULL
expressing	NULL
physiological	NULL
levels	NULL
of	NULL
nuclear	NULL
receptors	NULL
.	NULL

Therefore	NULL
we	NULL
analyzed	NULL
the	NULL
VDRE-binding	NULL
activity	NULL
in	NULL
unstimulated	NULL
and	NULL
VitD3-stimulated	NULL
U-937	NULL
cells	NULL
using	NULL
the	NULL
OC-VDRE	NULL
and	NULL
a	NULL
synthetic	NULL
DR-3-type	NULL
VDRE	NULL
in	NULL
EMSAs	NULL
.	NULL

Fig	NULL
.	NULL

24	NULL
shows	NULL
that	NULL
a	NULL
DNA-binding	NULL
complex	NULL
was	NULL
formed	NULL
on	NULL
the	NULL
OC-VDRE	NULL
after	NULL
VitD3	NULL
treatment	NULL
of	NULL
the	NULL
cells	NULL
for	NULL
72	NULL
h.	NULL
The	NULL
complex	NULL
was	NULL
specifically	NULL
competed	NULL
with	NULL
unlabeled	NULL
OC-VDRE	NULL
and	NULL
DR-3	NULL
VDRE	NULL
oligonucleotides	NULL
but	NULL
not	NULL
by	NULL
the	NULL
unrelated	NULL
oligonucleotide	NULL
PRDI	NULL
.	NULL

Notably	NULL
,	NULL
competition	NULL
with	NULL
excess	NULL
cold	NULL
B-RARE	NULL
also	NULL
abolished	NULL
the	NULL
OC-VDRE	NULL
DNA	NULL
binding	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Supershift	NULL
experiments	NULL
with	NULL
antibodies	NULL
directed	NULL
either	NULL
to	NULL
the	NULL
VDR	NULL
or	NULL
the	NULL
RXRs	NULL
indicated	NULL
that	NULL
the	NULL
OC-VDRE-binding	NULL
activity	NULL
was	NULL
composed	NULL
of	NULL
a	NULL
VDR/RXR	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
Lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
.	NULL

VitD3	NULL
induced	NULL
a	NULL
similar	NULL
DNA-binding	NULL
complex	NULL
on	NULL
the	NULL
DR-3	NULL
,	NULL
which	NULL
was	NULL
also	NULL
shown	NULL
to	NULL
be	NULL
composed	NULL
of	NULL
VDR	NULL
and	NULL
RXR	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
VitD3-induced	NULL
VDRE-binding	NULL
activity	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
U-937	NULL
cells	NULL
early	NULL
after	NULL
stimulation	NULL
and	NULL
persisted	NULL
throughout	NULL
the	NULL
differentiation	NULL
process	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
the	NULL
induced	NULL
DNA	NULL
binding	NULL
after	NULL
VitD3	NULL
stimulation	NULL
suggested	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
VDR/RXR	NULL
to	NULL
the	NULL
VDRE	NULL
resulted	NULL
from	NULL
recruitment	NULL
of	NULL
preexisting	NULL
VDR	NULL
and	NULL
RXRs	NULL
in	NULL
a	NULL
ligand-dependent	NULL
fashion	NULL
.	NULL

Indeed	NULL
,	NULL
Fig	NULL
.	NULL

2C	NULL
shows	NULL
that	NULL
VDR/	NULL
RXR	NULL
binding	NULL
could	NULL
be	NULL
induced	NULL
in	NULL
vitro	NULL
in	NULL
nuclear	NULL
extracts	NULL
1241	NULL
1242	NULL
-	NULL
VDR	NULL
,	NULL
RAR	NULL
,	NULL
and	NULL
RXR	NULL
Interactions	NULL
in	NULL
U-937	NULL
Cells	NULL
A	NULL
OC-VDRE*	NULL
<	NULL
B	NULL
&	NULL
0	NULL
«	NULL
»	NULL
0	NULL
€	NULL
go	NULL
$	NULL
9	NULL
=ﬂ	NULL
<	NULL
|	NULL
&	NULL
®	NULL
s	NULL
o	NULL
c	NULL
a	NULL
i	NULL
o	NULL
o	NULL
E	NULL
c	NULL
8	NULL
L	NULL
6	NULL
e	NULL
2	NULL
2	NULL
=	NULL
®	NULL
3	NULL
>	NULL
©	NULL
a	NULL
a	NULL
>	NULL
>	NULL
=	NULL
a	NULL
2	NULL
J	NULL
5	NULL
S	NULL
-p	NULL
-p	NULL
VDR/RXR	NULL
-	NULL
{	NULL
&	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
from	NULL
unstimulated	NULL
cells	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
VitD3	NULL
directly	NULL
to	NULL
the	NULL
DNA-binding	NULL
reaction	NULL
.	NULL

RA	NULL
Stimulation	NULL
Does	NULL
Not	NULL
interfere	NULL
with	NULL
VitD3-induced	NULL
VDR/RXR	NULL
Complex	NULL
Formation	NULL
or	NULL
VDRE-mediated	NULL
Tran-scription	NULL
.	NULL

Interference	NULL
between	NULL
VitD3	NULL
and	NULL
retinoid-signaling	NULL
pathways	NULL
through	NULL
the	NULL
common	NULL
coreceptor	NULL
RXR	NULL
has	NULL
been	NULL
observed	NULL
,	NULL
and	NULL
9cis-RA	NULL
stimulation	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
inhibit	NULL
VDR/RXR	NULL
DNA	NULL
binding	NULL
and	NULL
VDRE-dependent	NULL
transcription	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
RA	NULL
stimulation	NULL
would	NULL
inhibit	NULL
the	NULL
DNA-binding	NULL
or	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
VitD3-induced	NULL
VDR/RXR	NULL
complexes	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

No	NULL
specific	NULL
OC-VDRE	NULL
or	NULL
DR-3	NULL
binding	NULL
could	NULL
be	NULL
detected	NULL
after	NULL
at-RA	NULL
or	NULL
9cis-RA	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
Lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
simultaneous	NULL
treatment	NULL
of	NULL
U-937	NULL
cells	NULL
with	NULL
at-RA	NULL
or	NULL
9cis-RA	NULL
in	NULL
addition	NULL
to	NULL
VitD3	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
Lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
resulted	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
VDR/RXR	NULL
complex	NULL
in	NULL
the	NULL
EMSA	NULL
,	NULL
indistinguishable	NULL
from	NULL
that	NULL
induced	NULL
by	NULL
VitD3	NULL
alone	NULL
.	NULL

The	NULL
transcriptional	NULL
response	NULL
of	NULL
an	NULL
OC-VDRE-SV40	NULL
promoter-CAT	NULL
reporter	NULL
plasmid	NULL
(	NULL
OC-VDREpCAT	NULL
)	NULL
,	NULL
transiently	NULL
transfected	NULL
into	NULL
U-937	NULL
cells	NULL
,	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

In	NULL
repeated	NULL
experiments	NULL
,	NULL
VitD3	NULL
induced	NULL
an	NULL
approximately	NULL
4-fold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
compared	NULL
with	NULL
the	NULL
basal	NULL
activity	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

No	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
could	NULL
be	NULL
detected	NULL
after	NULL
at-RA	NULL
or	NULL
9cis-RA	NULL
stimulation	NULL
.	NULL

Costimulation	NULL
of	NULL
U-937	NULL
cells	NULL
with	NULL
VitD3	NULL
and	NULL
at-RA	NULL
or	NULL
9cis-RA	NULL
resulted	NULL
in	NULL
increased	NULL
levels	NULL
of	NULL
transcription	NULL
,	NULL
not	NULL
significantly	NULL
different	NULL
from	NULL
those	NULL
induced	NULL
by	NULL
VitD3	NULL
by	NULL
itself	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
OC-VDREpCAT	NULL
in	NULL
U-937	NULL
cells	NULL
correlated	NULL
with	NULL
the	NULL
induced	NULL
DNA	NULL
binding	NULL
of	NULL
VDR/RXR	NULL
.	NULL

at-RA	NULL
9	NULL
A	NULL
G	NULL
La	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

VDRE	NULL
binding	NULL
in	NULL
U-937	NULL
nuclear	NULL
extracts	NULL
after	NULL
induced	NULL
differentiation	NULL
.	NULL

U-937	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
72	NULL
h	NULL
as	NULL
indicated	NULL
with	NULL
VitD3	NULL
(	NULL
0.1	NULL
wm	NULL
)	NULL
,	NULL
at-RA	NULL
(	NULL
1.0	NULL
pM	NULL
)	NULL
,	NULL
Ocis-RA	NULL
(	NULL
0.1	NULL
um	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
10	NULL
nm	NULL
)	NULL
,	NULL
and	NULL
combinations	NULL
of	NULL
VitD3	NULL
and	NULL
RA	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
subjected	NULL
-	NULL
to	NULL
EMSA	NULL
.	NULL

A	NULL
,	NULL
DNA	NULL
binding	NULL
to	NULL
the	NULL
radiolabeled	NULL
OC-VDRE	NULL
.	NULL

Bottom	NULL
arrow	NULL
,	NULL
VitD3-induced	NULL
complex	NULL
visible	NULL
in	NULL
Lames	NULL
2	NULL
,	NULL
6	NULL
,	NULL
and	NULL
7	NULL
;	NULL
top	NULL
arrow	NULL
,	NULL
PMA-induced	NULL
DNA	NULL
binding	NULL
to	NULL
the	NULL
OC-VDRE	NULL
by	NULL
a	NULL
different	NULL
complex	NULL
,	NULL
identified	NULL
as	NULL
AP-1	NULL
binding	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

B	NULL
,	NULL
EMSA	NULL
set	NULL
up	NULL
as	NULL
in	NULL
A	NULL
but	NULL
with	NULL
labeled	NULL
DR-3	NULL
oligonucleotides	NULL
.	NULL

Lane	NULL
8	NULL
,	NULL
VDR	NULL
antibody	NULL
supershift	NULL
.	NULL

unstim	NULL
,	NULL
unstimulated	NULL
.	NULL

9cis-RA	NULL
PMA	NULL
VitD3+at-RA	NULL
VitD3+9cis-RA	NULL
VitD3	NULL
+	NULL
oV	NULL
|	NULL
WW	NULL
.	NULL

VDR/RXR	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
Phosphorylation	NULL
of	NULL
the	NULL
VDR	NULL
,	NULL
by	NULL
PKC	NULL
and	NULL
other	NULL
kinases	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
VDR	NULL
function	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

PKC	NULL
stimulation	NULL
by	NULL
PMA	NULL
in	NULL
U-937	NULL
cells	NULL
results	NULL
in	NULL
differentiation	NULL
toward	NULL
an	NULL
activated	NULL
monocyte-macrophage	NULL
phenotype	NULL
(	NULL
27	NULL
)	NULL
.	NULL

PMA	NULL
did	NULL
not	NULL
promote	NULL
any	NULL
VDR/RXR	NULL
binding	NULL
to	NULL
the	NULL
OC-VDRE	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

Instead	NULL
,	NULL
a	NULL
shifted	NULL
complex	NULL
of	NULL
slower	NULL
mobility	NULL
was	NULL
induced	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
Lane	NULL
5	NULL
)	NULL
,	NULL
which	NULL
was	NULL
specifically	NULL
competed	NULL
by	NULL
addition	NULL
of	NULL
cold	NULL
AP-1	NULL
oligonucleotide	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
band	NULL
thus	NULL
represents	NULL
AP-1	NULL
binding	NULL
to	NULL
the	NULL
consensus	NULL
AP-1	NULL
site	NULL
(	NULL
TGACTCA	NULL
)	NULL
in	NULL
the	NULL
3'-end	NULL
of	NULL
the	NULL
OC-VDRE	NULL
.	NULL

Similarly	NULL
,	NULL
PMA	NULL
did	NULL
not	NULL
induce	NULL
any	NULL
VDR/	NULL
RXR	NULL
binding	NULL
to	NULL
the	NULL
DR-3	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Increased	NULL
RAR-B/RXR	NULL
Binding	NULL
to	NULL
RAREs	NULL
after	NULL
RA	NULL
Stimulation	NULL
of	NULL
U-937	NULL
Cells	NULL
.	NULL

The	NULL
natural	NULL
RARE	NULL
in	NULL
the	NULL
promoter	NULL
(	NULL
B-RARE	NULL
)	NULL
was	NULL
used	NULL
to	NULL
investigate	NULL
the	NULL
retinoid	NULL
response	NULL
in	NULL
differentiating	NULL
U-937	NULL
cells	NULL
.	NULL

Gel	NULL
shift	NULL
assays	NULL
with	NULL
labeled	NULL
B-RARE	NULL
oligonucleotides	NULL
showed	NULL
that	NULL
three	NULL
major	NULL
DNA-binding	NULL
complexes	NULL
(	NULL
designated	NULL
I-III	NULL
)	NULL
were	NULL
formed	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
either	NULL
unstimulated	NULL
or	NULL
at-RA-stimulated	NULL
U-937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
.	NULL

These	NULL
complexes	NULL
(	NULL
I-i11	NULL
)	NULL
were	NULL
specifically	NULL
competed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
cold	NULL
B-RARE	NULL
oligonucleotides	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
Lanes	NULL
3-5	NULL
)	NULL
.	NULL

Competition	NULL
with	NULL
DR-3	NULL
or	NULL
OC-VDRE	NULL
oligonucleotides	NULL
preferentially	NULL
reduced	NULL
B-RARE-binding	NULL
complexes	NULL
|	NULL
and	NULL
III	NULL
but	NULL
only	NULL
marginally	NULL
affected	NULL
complex	NULL
II	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
Lanes	NULL
6-11	NULL
)	NULL
.	NULL

and	NULL
at-RA	NULL
treatment	NULL
resulted	NULL
in	NULL
enhanced	NULL
complex	NULL
II	NULL
formation	NULL
along	NULL
with	NULL
induction	NULL
of	NULL
the	NULL
differentiated	NULL
state	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Complex	NULL
II	NULL
could	NULL
be	NULL
supershifted	NULL
by	NULL
RXR	NULL
and	NULL
RAR-8	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
Lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

The	NULL
propor-	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
W	NULL
oc-vorEpcat	NULL
4	NULL
1	NULL
[	NULL
_	NULL
]	NULL
peat	NULL
fold	NULL
induction	NULL
G	NULL
VitD3	NULL
|	NULL
-	NULL
=	NULL
=	NULL
o=	NULL
-	NULL
#	NULL
0	NULL
#	NULL
+	NULL
#	NULL
at-RA	NULL
|	NULL
-	NULL
#	NULL
=	NULL
=-	NULL
o=	NULL
4	NULL
=-Qcis-RA	NULL
_-	NULL
=-	NULL
4+	NULL
=	NULL
O-	NULL
_+	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

OC-VDRE-dependent	NULL
transcriptional	NULL
activity	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

U-937	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
5	NULL
ug	NULL
OC-VDREpCAT	NULL
or	NULL
pCAT	NULL
plasmids	NULL
together	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
a	NULL
CMV-luciferase	NULL
construct	NULL
.	NULL

After	NULL
recovery	NULL
,	NULL
the	NULL
two	NULL
pools	NULL
of	NULL
OC-VDREpCAT-	NULL
and	NULL
pCAT-transfected	NULL
cells	NULL
were	NULL
split	NULL
and	NULL
stimulated	NULL
overnight	NULL
as	NULL
indicated	NULL
with	NULL
VitD3	NULL
(	NULL
0.1	NULL
um	NULL
)	NULL
,	NULL
at-RA	NULL
(	NULL
1.0	NULL
uy	NULL
)	NULL
,	NULL
and	NULL
9cis-RA	NULL
(	NULL
1.0	NULL
um	NULL
)	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
performed	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
and	NULL
quantification	NULL
in	NULL
an	NULL
image	NULL
analyzer	NULL
.	NULL

Top	NULL
panel	NULL
,	NULL
induced	NULL
CAT	NULL
activity	NULL
compared	NULL
with	NULL
the	NULL
basal	NULL
OC-VDREpCAT	NULL
transcription	NULL
that	NULL
was	NULL
set	NULL
to	NULL
1.0	NULL
.	NULL

The	NULL
mean	NULL
value	NULL
computed	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
,	NULL
each	NULL
with	NULL
duplicate	NULL
stimulations	NULL
and	NULL
CAT	NULL
assays	NULL
for	NULL
each	NULL
treatment	NULL
modality	NULL
,	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
values	NULL
for	NULL
pCAT	NULL
induction	NULL
in	NULL
relation	NULL
to	NULL
OC-VDRE-activity	NULL
were	NULL
correlated	NULL
to	NULL
luciferase	NULL
levels	NULL
in	NULL
the	NULL
cell	NULL
lysates	NULL
.	NULL

Bottom	NULL
panel	NULL
,	NULL
OC-VDRE-mediated	NULL
transcriptional	NULL
response	NULL
from	NULL
one	NULL
representative	NULL
experiment	NULL
.	NULL

tion	NULL
of	NULL
complex	NULL
II	NULL
that	NULL
was	NULL
supershifted	NULL
by	NULL
RAR-8	NULL
antibodies	NULL
increased	NULL
during	NULL
retinoid-induced	NULL
differentiation	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
increased	NULL
expression	NULL
of	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
remaining	NULL
part	NULL
of	NULL
complex	NULL
II	NULL
could	NULL
possibly	NULL
be	NULL
explained	NULL
by	NULL
an	NULL
incomplete	NULL
supershift	NULL
by	NULL
the	NULL
RAR-	NULL
$	NULL
antibody	NULL
.	NULL

Alternatively	NULL
,	NULL
other	NULL
RAR/RXR	NULL
dimers	NULL
or	NULL
other	NULL
nuclear	NULL
receptors	NULL
com-plexed	NULL
to	NULL
RXR	NULL
might	NULL
constitute	NULL
part	NULL
of	NULL
complex	NULL
II	NULL
.	NULL

The	NULL
VDR	NULL
and	NULL
RAR-a	NULL
antibodies	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
mobility	NULL
of	NULL
complex	NULL
II	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
Lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

VitD3	NULL
Inhibits	NULL
RAR-B/RXR	NULL
Formation	NULL
and	NULL
Induces	NULL
VDR/RXR	NULL
Binding	NULL
to	NULL
RAREs	NULL
.	NULL

VitD3	NULL
stimulation	NULL
strongly	NULL
induced	NULL
the	NULL
formation	NULL
of	NULL
complex	NULL
III	NULL
on	NULL
the	NULL
B-RARE	NULL
(	NULL
Fig	NULL
.	NULL

58	NULL
)	NULL
.	NULL

Supershift	NULL
experiments	NULL
showed	NULL
that	NULL
complex	NULL
III	NULL
was	NULL
composed	NULL
of	NULL
a	NULL
VDR/RXR	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
Lanes	NULL
6-8	NULL
)	NULL
.	NULL

RAR-	NULL
«	NULL
or	NULL
RAR-8	NULL
antibodies	NULL
did	NULL
not	NULL
supershift	NULL
complex	NULL
III	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
cotreatment	NULL
of	NULL
U-937	NULL
cells	NULL
with	NULL
VitD3	NULL
and	NULL
a	NULL
retinoid	NULL
also	NULL
resulted	NULL
in	NULL
strong	NULL
complex	NULL
III	NULL
formation	NULL
,	NULL
whereas	NULL
the	NULL
amount	NULL
of	NULL
RAR-B/RXR	NULL
(	NULL
complex	NULL
II	NULL
)	NULL
bound	NULL
to	NULL
the	NULL
B-RARE	NULL
was	NULL
selectively	NULL
reduced	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
Lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
complex	NULL
I	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
affected	NULL
by	NULL
VitD3	NULL
stimulation	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
RAR-8/	NULL
RXR	NULL
promoted	NULL
by	NULL
RA	NULL
was	NULL
distinctly	NULL
inhibited	NULL
by	NULL
VitD3	NULL
stimulation	NULL
in	NULL
a	NULL
dominant	NULL
fashion	NULL
when	NULL
U-937	NULL
cells	NULL
were	NULL
stimulated	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
VitD3	NULL
and	NULL
RA	NULL
.	NULL

The	NULL
DR-2	NULL
EMSA	NULL
in	NULL
Fig	NULL
.	NULL

5D	NULL
yielded	NULL
a	NULL
DNA-binding	NULL
pattern	NULL
similar	NULL
to	NULL
that	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
performed	NULL
with	NULL
the	NULL
B-RARE	NULL
,	NULL
and	NULL
in	NULL
supershift	NULL
experiments	NULL
,	NULL
DR-2-binding	NULL
complexes	NULL
II	NULL
and	NULL
III	NULL
reacted	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
gel	NULL
shift	NULL
results	NULL
using	NULL
an	NULL
everted	NULL
repeat	NULL
type	NULL
RARE	NULL
from	NULL
the	NULL
yF-crystallin	NULL
promoter	NULL
(	NULL
28	NULL
)	NULL
resembled	NULL
those	NULL
obtained	NULL
with	NULL
the	NULL
B-RARE	NULL
and	NULL
DR-2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

RARE-mediated	NULL
Transcriptional	NULL
Activation	NULL
during	NULL
Retinoid	NULL
Treatment	NULL
of	NULL
U-937	NULL
Cells	NULL
Is	NULL
Not	NULL
Affected	NULL
by	NULL
VitD3	NULL
.	NULL

Transient	NULL
transfections	NULL
of	NULL
U-937	NULL
cells	NULL
with	NULL
a	NULL
B-RAREpCAT	NULL
reporter	NULL
construct	NULL
and	NULL
subsequent	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
to	NULL
examine	NULL
the	NULL
transcriptional	NULL
response	NULL
induced	NULL
through	NULL
the	NULL
B-RARE	NULL
during	NULL
U-937	NULL
differentiation	NULL
.	NULL

In	NULL
a	NULL
series	NULL
of	NULL
experiments	NULL
,	NULL
at-RA	NULL
and	NULL
9cis-RA	NULL
induced	NULL
an	NULL
approximately	NULL
10-20-fold	NULL
increase	NULL
in	NULL
B-RAREpCAT	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

9cis-RA	NULL
tended	NULL
to	NULL
promote	NULL
slightly	NULL
higher	NULL
levels	NULL
of	NULL
CAT	NULL
activity	NULL
.	NULL

No	NULL
transcriptional	NULL
response	NULL
was	NULL
elicited	NULL
by	NULL
VitD3	NULL
stimulation	NULL
.	NULL

Concomitant	NULL
VitD3	NULL
and	NULL
RA	NULL
stimulation	NULL
induced	NULL
levels	NULL
of	NULL
B-RARE-dependent	NULL
transcription	NULL
comparable	NULL
to	NULL
those	NULL
induced	NULL
by	NULL
at-RA	NULL
and	NULL
9cis-RA	NULL
alone	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
transcriptional	NULL
response	NULL
of	NULL
a	NULL
DR-2pCAT	NULL
reporter	NULL
resembled	NULL
the	NULL
B-RAREpCAT	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

The	NULL
retinoids	NULL
,	NULL
by	NULL
themselves	NULL
and	NULL
in	NULL
combination	NULL
with	NULL
VitD3	NULL
,	NULL
activated	NULL
DR-2pCAT	NULL
transcription	NULL
,	NULL
whereas	NULL
VitD3	NULL
alone	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
two	NULL
protocols	NULL
that	NULL
promoted	NULL
a	NULL
similar	NULL
increase	NULL
in	NULL
RARE-dependent	NULL
transcription	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
stimulation	NULL
with	NULL
RA	NULL
or	NULL
RA	NULL
plus	NULL
VitD3	NULL
,	NULL
at	NULL
the	NULL
same	NULL
time	NULL
induced	NULL
unique	NULL
DNA-binding	NULL
patterns	NULL
in	NULL
the	NULL
B-RARE	NULL
EMSA	NULL
(	NULL
Figs	NULL
.	NULL

58	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Retinoid-specific	NULL
Differentiation	NULL
Genes	NULL
Are	NULL
Suppressed	NULL
by	NULL
VitD3	NULL
.	NULL

RA-induced	NULL
transcriptional	NULL
activation	NULL
of	NULL
RAREs	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
VitD3	NULL
stimulation	NULL
,	NULL
and	NULL
con-versely	NULL
,	NULL
VitD3-induced	NULL
VDRE-mediated	NULL
transcription	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
RA	NULL
treatment	NULL
.	NULL

Consequently	NULL
,	NULL
both	NULL
RA-	NULL
and	NULL
VitD3-stimulated	NULL
gene	NULL
expression	NULL
should	NULL
be	NULL
permitted	NULL
in	NULL
cells	NULL
during	NULL
stimulation	NULL
with	NULL
both	NULL
ligands	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
CD14	NULL
,	NULL
a	NULL
VitD3-induced	NULL
monocytic	NULL
differentiation	NULL
antigen	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
up-regulated	NULL
by	NULL
VitD3	NULL
and	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
VitD3	NULL
and	NULL
RA	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
;	NULL
Ref	NULL
.	NULL

22	NULL
)	NULL
,	NULL
analogous	NULL
to	NULL
the	NULL
OC-VDREpCAT	NULL
activity	NULL
.	NULL

Also	NULL
,	NULL
RAR-B	NULL
mRNA	NULL
was	NULL
strongly	NULL
up-regulated	NULL
by	NULL
at-RA	NULL
and	NULL
9cis-RA	NULL
treatment	NULL
and	NULL
by	NULL
costimulation	NULL
with	NULL
retinoid	NULL
and	NULL
VitD3	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
,	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
observed	NULL
B-RAREpCAT	NULL
activity	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
retinoid-induced	NULL
expression	NULL
of	NULL
the	NULL
CD23	NULL
and	NULL
CD49f	NULL
differentiation	NULL
antigens	NULL
was	NULL
inhibited	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
VitD3	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
;	NULL
Refs	NULL
.	NULL

22	NULL
and	NULL
23	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
two	NULL
kinds	NULL
of	NULL
genes	NULL
seem	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
retinoids	NULL
during	NULL
U-937	NULL
differentiation	NULL
.	NULL

RARE-regulated	NULL
genes	NULL
such	NULL
as	NULL
RAR-B	NULL
are	NULL
not	NULL
suppressed	NULL
by	NULL
VitD3	NULL
,	NULL
while	NULL
genes	NULL
upregulated	NULL
later	NULL
in	NULL
the	NULL
differentiation	NULL
process	NULL
,	NULL
such	NULL
as	NULL
CD23	NULL
and	NULL
CD49f	NULL
,	NULL
are	NULL
inhibited	NULL
by	NULL
VitD3	NULL
.	NULL

It	NULL
should	NULL
be	NULL
emphasized	NULL
that	NULL
the	NULL
basic	NULL
differentiation	NULL
program	NULL
1243	NULL
1244	NULL
-	NULL
VDR	NULL
,	NULL
RAR	NULL
,	NULL
and	NULL
RXR	NULL
Interactions	NULL
in	NULL
U-937	NULL
Cells	NULL
BRARE*	NULL
A	NULL
B	NULL
BRARE*	NULL
at-RA	NULL
4h	NULL
I	NULL
1	NULL
<	NULL
£	NULL
<	NULL
&	NULL
C	NULL
‘	NULL
é	NULL
“	NULL
ARE	NULL
pat	NULL
ONO	NULL
“	NULL
pRD\	NULL
F'-	NULL
§	NULL
3	NULL
35	NULL
“	NULL
O0	NULL
-all	NULL
_	NULL
E	NULL
é	NULL
2	NULL
+	NULL
«	NULL
=	NULL
4°	NULL
o	NULL
o	NULL
o	NULL
o	NULL
£	NULL
2	NULL
o	NULL
o	NULL
o	NULL
c	NULL
L	NULL
o	NULL
2	NULL
2	NULL
2	NULL
3	NULL
a	NULL
a	NULL
>	NULL
>	NULL
>	NULL
I	NULL
-	NULL
»	NULL
I	NULL
-	NULL
»	NULL
;	NULL
l	NULL
III	NULL
-	NULL
»	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

DNA-binding	NULL
activity	NULL
in	NULL
U-937	NULL
cell	NULL
nuclear	NULL
extracts	NULL
to	NULL
radiolabeled	NULL
RAREs	NULL
,	NULL
A	NULL
,	NULL
EMSA	NULL
on	NULL
DNA	NULL
binding	NULL
to	NULL
the	NULL
B-RARE	NULL
in	NULL
unstimulated	NULL
(	NULL
unstim	NULL
)	NULL
and	NULL
at-RA-stimu-lated	NULL
(	NULL
1.0	NULL
um	NULL
for	NULL
4	NULL
h	NULL
)	NULL
U-937	NULL
cells	NULL
,	NULL
Three	NULL
dominating	NULL
DNA-binding	NULL
complexes	NULL
,	NULL
designated	NULL
|-I	NULL
!	NULL

l	NULL
,	NULL
were	NULL
formed	NULL
.	NULL

Competitions	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11121314	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
with	NULL
cold	NULL
oligonucleotides	NULL
were	NULL
performed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
.	NULL

B	NULL
,	NULL
B-RARE	NULL
EMSA	NULL
with	NULL
nu-*	NULL
_o	NULL
#	NULL
clear	NULL
extracts	NULL
from	NULL
U-937	NULL
cells	NULL
stimulated	NULL
c	NULL
BRARE	NULL
D	NULL
DR-2	NULL
for	NULL
72	NULL
h	NULL
with	NULL
at-RA	NULL
(	NULL
1.0	NULL
um	NULL
)	NULL
,	NULL
Icis-RA	NULL
(	NULL
0.1	NULL
P	NULL
pM	NULL
)	NULL
,	NULL
VitD3	NULL
(	NULL
0.1	NULL
ww	NULL
)	NULL
,	NULL
and	NULL
VitD	NULL
and	NULL
at-RA	NULL
or	NULL
9cis-RA	NULL
VitD3	NULL
¢	NULL
&	NULL
Icis-RA	NULL
.	NULL

The	NULL
excess	NULL
free	NULL
B-RARE	NULL
probe	NULL
s	NULL
a.	NULL
a	NULL
&	NULL
was	NULL
run	NULL
out	NULL
of	NULL
the	NULL
gel	NULL
.	NULL

C	NULL
,	NULL
B-RARE	NULL
EMSA	NULL
;	NULL
£	NULL
E	NULL
C	NULL
®	NULL
a	NULL
E	NULL
é	NULL
3	NULL
supershift	NULL
experiment	NULL
with	NULL
antibodies	NULL
di-a	NULL
4	NULL
4	NULL
x	NULL
6	NULL
x	NULL
en	NULL
¢	NULL
©	NULL
9	NULL
rected	NULL
to	NULL
the	NULL
VDR	NULL
,	NULL
RARs	NULL
,	NULL
and	NULL
RXRs	NULL
as	NULL
3	NULL
g	NULL
m5	NULL
m5	NULL
a	NULL
lg	NULL
<	NULL
é	NULL
6	NULL
8	NULL
8	NULL
B	NULL
indicated	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
supershifted	NULL
+o	NULL
bP	NULL
t	NULL
4	NULL
oa	NULL
+	NULL
+	NULL
5	NULL
&	NULL
g	NULL
2	NULL
€	NULL
§	NULL
bands	NULL
(	NULL
*	NULL
)	NULL
blend	NULL
with	NULL
complex	NULL
|	NULL
.	NULL

Nuclear	NULL
'	NULL
3	NULL
®	NULL
>	NULL
>	NULL
extracts	NULL
were	NULL
from	NULL
U-937	NULL
cells	NULL
after	NULL
72	NULL
h	NULL
of	NULL
or	NULL
VitD3	NULL
stimulation	NULL
.	NULL

D	NULL
,	NULL
DR-2	NULL
R	NULL
RARE	NULL
EMSA	NULL
set	NULL
up	NULL
as	NULL
in	NULL
B	NULL
.	NULL

1	NULL
«	NULL
*~	NULL
g	NULL
¢	NULL
'	NULL
RARR/RXR	NULL
I-	NULL
»	NULL
.	NULL
``	NULL

Cl	NULL
VDRRXR	NULL
s	NULL
f	NULL
I	NULL
-	NULL
»	NULL
f	NULL
BL	NULL
f	NULL
...	NULL
..	NULL
m-	NULL
W	NULL
Mb..	NULL
uu	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
*I	NULL
i	NULL
piktt	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
]	NULL
B	NULL
srarepcat	NULL
[	NULL
]	NULL
peat	NULL
fold	NULL
induction	NULL
ho	NULL
U	NULL
[	NULL
(	NULL
«	NULL
]	NULL
&	NULL
wah	NULL
&	NULL
sae	NULL
wis	NULL
at-RA	NULL
|	NULL
-	NULL
=	NULL
-o	NULL
#	NULL
o=	NULL
4	NULL
=	NULL
Qcis-RA	NULL
-	NULL
-	NULL
=o	NULL
=	NULL
0	NULL
$	NULL
o	NULL
00-0	NULL
+4	NULL
VitD3	NULL
|	NULL
=	NULL
=	NULL
4+	NULL
=	NULL
-	NULL
4+	NULL
+	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Transcriptional	NULL
activation	NULL
via	NULL
the	NULL
B-RARE	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
electroporated	NULL
with	NULL
10	NULL
ug	NULL
B-RAREpCAT	NULL
or	NULL
pCAT	NULL
reporters	NULL
along	NULL
with	NULL
5	NULL
ug	NULL
CMV-luciferase	NULL
plasmid	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
treated	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Duplicate	NULL
stimulations	NULL
were	NULL
performed	NULL
in	NULL
each	NULL
experiment	NULL
,	NULL
and	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
experiments	NULL
is	NULL
shown	NULL
in	NULL
the	NULL
top	NULL
panel	NULL
.	NULL

Bottom	NULL
panel	NULL
,	NULL
CAT	NULL
activity	NULL
driven	NULL
by	NULL
the	NULL
B-RARE	NULL
from	NULL
one	NULL
representative	NULL
experiment	NULL
.	NULL

is	NULL
intact	NULL
during	NULL
costimulation	NULL
with	NULL
VitD3	NULL
and	NULL
RA	NULL
.	NULL

Induced	NULL
CD11c	NULL
expression	NULL
and	NULL
growth	NULL
arrest	NULL
in	NULL
G	NULL
,	NULL
-G	NULL
,	NULL
are	NULL
well-de-fined	NULL
characteristics	NULL
of	NULL
differentiated	NULL
U-937	NULL
cells	NULL
.	NULL

Table	NULL
1	NULL
shows	NULL
that	NULL
U-937	NULL
cells	NULL
stimulated	NULL
with	NULL
both	NULL
at-RA	NULL
and	NULL
VitD3	NULL
retain	NULL
these	NULL
characteristics	NULL
of	NULL
terminal	NULL
differentiation	NULL
,	NULL
although	NULL
the	NULL
late	NULL
RA-specific	NULL
differentiation	NULL
genes	NULL
displayed	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
CD23	NULL
and	NULL
CD49f	NULL
,	NULL
are	NULL
suppressed	NULL
.	NULL

Discussion	NULL
Retinoids	NULL
and	NULL
VitD3	NULL
are	NULL
potent	NULL
inducers	NULL
of	NULL
differentiation	NULL
of	NULL
normal	NULL
and	NULL
malignant	NULL
myeloid	NULL
precursor	NULL
cells	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

We	NULL
have	NULL
investigated	NULL
the	NULL
signaling	NULL
through	NULL
RA	NULL
and	NULL
VitD3	NULL
response	NULL
elements	NULL
during	NULL
induced	NULL
monocytic	NULL
differentiation	NULL
.	NULL

The	NULL
U-937	NULL
cell	NULL
line	NULL
serves	NULL
as	NULL
an	NULL
excellent	NULL
model	NULL
system	NULL
for	NULL
studies	NULL
on	NULL
the	NULL
basic	NULL
DNA-binding	NULL
and	NULL
transcriptional	NULL
activity	NULL
of	NULL
endogenous	NULL
nuclear	NULL
receptors	NULL
in	NULL
a	NULL
biological	NULL
context	NULL
,	NULL
in	NULL
which	NULL
RA	NULL
and	NULL
VitD3	NULL
have	NULL
distinct	NULL
and	NULL
well-characterized	NULL
effects	NULL
on	NULL
the	NULL
cell	NULL
phenotype	NULL
.	NULL

Several	NULL
nuclear	NULL
steroid	NULL
receptor	NULL
complexes	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
VDRE	NULL
activity	NULL
(	NULL
13-16	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
demonstrate	NULL
by	NULL
gel	NULL
shift	NULL
assays	NULL
that	NULL
VitD3	NULL
treatment	NULL
of	NULL
U-937	NULL
cells	NULL
resulted	NULL
in	NULL
one	NULL
major	NULL
specific	NULL
VDRE-binding	NULL
complex	NULL
composed	NULL
of	NULL
VDR	NULL
and	NULL
RXR	NULL
.	NULL

The	NULL
induced	NULL
DNA	NULL
binding	NULL
of	NULL
VDR/	NULL
C	NULL
o	NULL
9	NULL
a	NULL
>	NULL
<	NULL
z	NULL
4	NULL
E	NULL
»	NULL
<	NULL
L	NULL
<	NULL
C	NULL
=	NULL
A	NULL
C	NULL
4	NULL
C	NULL
.	NULL

$	NULL
s	NULL
5	NULL
s	NULL
8	NULL
8	NULL
8	NULL
(	NULL
p	NULL
)	NULL
RARB	NULL
th	NULL
ae	NULL
wan	NULL
wan	NULL
=	NULL
-	NULL
5.5	NULL
CD2s	NULL
(	NULL
Te	NULL
-1.7	NULL
Ccosgf	NULL
--	NULL
__	NULL
-s.0	NULL
CD14	NULL
last	NULL
mad	NULL
bust	NULL
=	NULL
-	NULL
1.	NULL
acin	NULL
-	NULL
2.0	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Expression	NULL
of	NULL
differentiation	NULL
antigens	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

Northern	NULL
biot	NULL
analysis	NULL
of	NULL
15	NULL
ug	NULL
total	NULL
cellular	NULL
RNA	NULL
from	NULL
cells	NULL
stimulated	NULL
for	NULL
72	NULL
h	NULL
with	NULL
VitD3	NULL
(	NULL
0.1	NULL
um	NULL
)	NULL
,	NULL
at-RA	NULL
(	NULL
1.0	NULL
uw	NULL
)	NULL
,	NULL
9cis-RA	NULL
(	NULL
1.0	NULL
uw	NULL
)	NULL
,	NULL
and	NULL
combinations	NULL
of	NULL
VitD3	NULL
and	NULL
RA	NULL
.	NULL

The	NULL
filter	NULL
was	NULL
hybridized	NULL
with	NULL
°°P-labeled	NULL
probes	NULL
to	NULL
the	NULL
RAR-B	NULL
,	NULL
CD23	NULL
,	NULL
CD49f	NULL
,	NULL
CD14	NULL
,	NULL
and	NULL
a-actin	NULL
mRNA	NULL
transcripts	NULL
.	NULL

unstim	NULL
,	NULL
unstimulated	NULL
.	NULL

RXR	NULL
correlated	NULL
with	NULL
increased	NULL
VDRE-mediated	NULL
transcription	NULL
in	NULL
U-937	NULL
cells	NULL
and	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
CD14	NULL
gene	NULL
expression	NULL
,	NULL
a	NULL
marker	NULL
for	NULL
VitD3-induced	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
recruitment	NULL
of	NULL
VDR	NULL
and	NULL
RXR	NULL
to	NULL
VDREs	NULL
seemed	NULL
to	NULL
be	NULL
the	NULL
first	NULL
step	NULL
in	NULL
the	NULL
monocytic	NULL
differentiation	NULL
program	NULL
promoted	NULL
by	NULL
VitD3	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
up-regulation	NULL
of	NULL
RXR	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
and	NULL
protein	NULL
(	NULL
29	NULL
)	NULL
during	NULL
VitD3-induced	NULL
differentiation	NULL
could	NULL
facilitate	NULL
the	NULL
VDR/RXR	NULL
binding	NULL
observed	NULL
at	NULL
late	NULL
time	NULL
points	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
VitD3	NULL
is	NULL
required	NULL
as	NULL
an	NULL
inducer	NULL
of	NULL
VDR/RXR	NULL
DNA	NULL
binding	NULL
in	NULL
U-937	NULL
cells	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
original	NULL
studies	NULL
showing	NULL
that	NULL
recombinant	NULL
VDR	NULL
needs	NULL
a	NULL
ligand	NULL
and	NULL
a	NULL
mammalian	NULL
factor	NULL
,	NULL
/.e	NULL
.	NULL

,	NULL
RXR	NULL
,	NULL
for	NULL
high-affinity	NULL
VDRE	NULL
binding	NULL
(	NULL
30	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
need	NULL
for	NULL
VitD3	NULL
seems	NULL
relative	NULL
and	NULL
tissue	NULL
specific	NULL
.	NULL

For	NULL
example	NULL
,	NULL
in	NULL
rat	NULL
osteosarcoma	NULL
cells	NULL
,	NULL
both	NULL
VitD3-dependent	NULL
and	NULL
-independent	NULL
regulation	NULL
of	NULL
VDR-VDRE	NULL
interactions	NULL
have	NULL
been	NULL
suggested	NULL
(	NULL
31-33	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
both	NULL
synergism	NULL
and	NULL
antagonism	NULL
between	NULL
VitD3	NULL
and	NULL
RA	NULL
on	NULL
VDR/	NULL
RXR-mediated	NULL
transcription	NULL
and	NULL
DNA	NULL
binding	NULL
have	NULL
been	NULL
reported	NULL
(	NULL
13	NULL
,	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Yet	NULL
,	NULL
in	NULL
U-937	NULL
cells	NULL
expressing	NULL
physio-	NULL
1245	NULL
1246	NULL
-	NULL
VDR	NULL
,	NULL
RAR	NULL
,	NULL
and	NULL
RXR	NULL
Interactions	NULL
in	NULL
U-937	NULL
Cells	NULL
Table	NULL
1	NULL
-	NULL
CD11c	NULL
expression	NULL
and	NULL
cell	NULL
cycle	NULL
distribution	NULL
after	NULL
induced	NULL
U-937	NULL
cell	NULL
differentiation	NULL
U-937	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
96	NULL
h	NULL
with	NULL
VitD3	NULL
(	NULL
0.1	NULL
my	NULL
)	NULL
and	NULL
at-RA	NULL
(	NULL
1.0	NULL
mm	NULL
)	NULL
as	NULL
indicated	NULL
,	NULL
and	NULL
the	NULL
cell	NULL
cycle	NULL
distribution	NULL
and	NULL
CD11c	NULL
expression	NULL
were	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Results	NULL
are	NULL
displayed	NULL
as	NULL
percentages	NULL
of	NULL
positive	NULL
cells	NULL
.	NULL

Unstimulated	NULL
at-RA	NULL
VitD3	NULL
at-RA	NULL
+	NULL
VitD3	NULL
Cell	NULL
cycle	NULL
phase	NULL
(	NULL
%	NULL
)	NULL
Gy-Gq	NULL
60.3	NULL
96.7	NULL
95.4	NULL
94.2	NULL
S	NULL
34.0	NULL
2.1	NULL
2.4	NULL
1.5	NULL
Gz-M	NULL
5.7	NULL
1.2	NULL
2.2	NULL
4.3	NULL
CD1	NULL
1c	NULL
expression	NULL
(	NULL
%	NULL
)	NULL
7.2	NULL
85.1	NULL
61.7	NULL
76.5	NULL
logical	NULL
levels	NULL
of	NULL
receptors	NULL
,	NULL
VitD3	NULL
and	NULL
RA	NULL
appeared	NULL
neither	NULL
synergistic	NULL
nor	NULL
antagonistic	NULL
with	NULL
regard	NULL
to	NULL
the	NULL
VitD3	NULL
re-sponse	NULL
.	NULL

Costimulation	NULL
of	NULL
U-937	NULL
cells	NULL
with	NULL
either	NULL
at-RA	NULL
or	NULL
9cis-RA	NULL
and	NULL
VitD3	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
VitD3-induced	NULL
VDR/RXR	NULL
binding	NULL
or	NULL
the	NULL
VitD3-induced	NULL
transcriptional	NULL
response	NULL
of	NULL
the	NULL
OC-VDREpCAT	NULL
reporter	NULL
.	NULL

Likewise	NULL
,	NULL
the	NULL
VitD3-induced	NULL
expression	NULL
of	NULL
CD14	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
concomitant	NULL
at-RA	NULL
or	NULL
9cis-RA	NULL
stimulation	NULL
.	NULL

Interestingly	NULL
,	NULL
VitD3	NULL
also	NULL
induced	NULL
VDR/	NULL
RXR	NULL
binding	NULL
to	NULL
the	NULL
B-RARE	NULL
.	NULL

However	NULL
,	NULL
in	NULL
this	NULL
case	NULL
,	NULL
no	NULL
effect	NULL
on	NULL
B-RARE-mediated	NULL
transcriptional	NULL
activity	NULL
was	NULL
detected	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
VDR/RXR	NULL
complex	NULL
was	NULL
bound	NULL
to	NULL
the	NULL
B-RARE	NULL
in	NULL
a	NULL
conformation	NULL
that	NULL
did	NULL
not	NULL
allow	NULL
VitD3-induced	NULL
transcriptional	NULL
activation	NULL
to	NULL
occur	NULL
.	NULL

Endogenous	NULL
factors	NULL
in	NULL
P19	NULL
carcinoma	NULL
cell	NULL
,	NULL
chick	NULL
lens	NULL
,	NULL
and	NULL
keratinocyte	NULL
nuclear	NULL
extracts	NULL
form	NULL
multiple	NULL
DNA-binding	NULL
complexes	NULL
on	NULL
RAREs	NULL
in	NULL
gel	NULL
shift	NULL
assays	NULL
(	NULL
28	NULL
,	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
composition	NULL
of	NULL
these	NULL
different	NULL
RARE-binding	NULL
complexes	NULL
is	NULL
unclear	NULL
,	NULL
and	NULL
their	NULL
role	NULL
as	NULL
regulators	NULL
of	NULL
transcriptional	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
RA	NULL
stimulation	NULL
is	NULL
not	NULL
known	NULL
.	NULL

In	NULL
unstimulated	NULL
U-937	NULL
cells	NULL
,	NULL
three	NULL
major	NULL
DNA-binding	NULL
complexes	NULL
(	NULL
-ll	NULL
!	NULL
)	NULL

were	NULL
formed	NULL
in	NULL
the	NULL
B-RARE	NULL
EMSA	NULL
.	NULL

During	NULL
induced	NULL
differentiation	NULL
of	NULL
U-937	NULL
cells	NULL
with	NULL
retinoids	NULL
,	NULL
the	NULL
formation	NULL
of	NULL
complex	NULL
II	NULL
was	NULL
enhanced	NULL
,	NULL
and	NULL
this	NULL
complex	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
composed	NULL
of	NULL
RAR-8	NULL
and	NULL
RXR	NULL
by	NULL
supershift	NULL
experiments	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
RAR-B/RXR	NULL
binding	NULL
correlated	NULL
with	NULL
RA-induced	NULL
B-RAREpCAT	NULL
activity	NULL
,	NULL
up-regulated	NULL
RAR-8	NULL
mRNA	NULL
expression	NULL
,	NULL
and	NULL
initiation	NULL
of	NULL
the	NULL
retinoid-specific	NULL
differentiation	NULL
program	NULL
,	NULL
as	NULL
illustrated	NULL
by	NULL
induction	NULL
of	NULL
CD23	NULL
and	NULL
CD49f	NULL
expression	NULL
.	NULL

As	NULL
in	NULL
embryonal	NULL
carcinoma	NULL
cells	NULL
(	NULL
36	NULL
)	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
RAR-B	NULL
provides	NULL
a	NULL
positive	NULL
feedback	NULL
signal	NULL
during	NULL
the	NULL
RA-induced	NULL
differentiation	NULL
process	NULL
.	NULL

Up-regulation	NULL
of	NULL
RAR-6	NULL
might	NULL
be	NULL
important	NULL
for	NULL
the	NULL
development	NULL
of	NULL
a	NULL
fully	NULL
differentiated	NULL
cell	NULL
phenotype	NULL
.	NULL

For	NULL
example	NULL
,	NULL
RAR-8B	NULL
,	NULL
but	NULL
not	NULL
RAR-a	NULL
or	NULL
-y	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
mediate	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
gene	NULL
after	NULL
RA	NULL
stimulation	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
RAR-B	NULL
has	NULL
been	NULL
implicated	NULL
as	NULL
a	NULL
regulator	NULL
of	NULL
terminal	NULL
growth	NULL
arrest	NULL
,	NULL
and	NULL
RAR-B	NULL
expression	NULL
is	NULL
down-regulated	NULL
in	NULL
several	NULL
forms	NULL
of	NULL
cancer	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
U-937	NULL
cells	NULL
the	NULL
RA-induced	NULL
binding	NULL
of	NULL
RAR-B/RXR	NULL
to	NULL
RAREs	NULL
was	NULL
inhibited	NULL
by	NULL
VitD3	NULL
stimulation	NULL
.	NULL

Instead	NULL
,	NULL
VitD3	NULL
promoted	NULL
DNA	NULL
binding	NULL
of	NULL
VDR/RXR	NULL
to	NULL
the	NULL
B-RARE	NULL
.	NULL

Competition	NULL
for	NULL
a	NULL
limiting	NULL
amount	NULL
of	NULL
the	NULL
cofactor	NULL
RXR	NULL
between	NULL
different	NULL
pools	NULL
of	NULL
nuclear	NULL
hormone	NULL
receptors	NULL
has	NULL
been	NULL
described	NULL
in	NULL
experiments	NULL
with	NULL
purified	NULL
or	NULL
overexpressed	NULL
receptors	NULL
and	NULL
could	NULL
account	NULL
for	NULL
the	NULL
observed	NULL
an	NULL
tagonism	NULL
between	NULL
some	NULL
nuclear	NULL
receptor-signaling	NULL
pathways	NULL
(	NULL
17	NULL
,	NULL
39	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
show	NULL
,	NULL
for	NULL
the	NULL
first	NULL
time	NULL
,	NULL
a	NULL
ligand-dependent	NULL
change	NULL
in	NULL
DNA	NULL
binding	NULL
from	NULL
RAR/RXR	NULL
to	NULL
VDR/	NULL
RXR	NULL
occuring	NULL
at	NULL
physiological	NULL
levels	NULL
of	NULL
endogenously	NULL
expressed	NULL
receptors	NULL
.	NULL

However	NULL
,	NULL
despite	NULL
this	NULL
antagonism	NULL
between	NULL
RA	NULL
and	NULL
VitD3	NULL
at	NULL
the	NULL
DNA-binding	NULL
level	NULL
,	NULL
the	NULL
RARE-mediated	NULL
transcription	NULL
remained	NULL
high	NULL
during	NULL
costimulation	NULL
of	NULL
U-937	NULL
cells	NULL
with	NULL
RA	NULL
and	NULL
VitD3	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
reasonable	NULL
to	NULL
assume	NULL
that	NULL
complexes	NULL
other	NULL
than	NULL
RAR-B/RXR	NULL
(	NULL
complex	NULL
11	NULL
)	NULL
participated	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
B-RARE	NULL
after	NULL
RA	NULL
and	NULL
VitD3	NULL
stimulation	NULL
,	NULL
/.e	NULL
.	NULL

,	NULL
complex	NULL
I	NULL
or	NULL
III	NULL
.	NULL

Complex	NULL
t	NULL
appeared	NULL
as	NULL
a	NULL
diffuse	NULL
band	NULL
of	NULL
slow	NULL
mobility	NULL
in	NULL
the	NULL
EMSAs	NULL
and	NULL
could	NULL
harbor	NULL
several	NULL
multimeric	NULL
complexes	NULL
composed	NULL
of	NULL
receptors	NULL
and	NULL
various	NULL
coactivators	NULL
and	NULL
corepressors	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
role	NULL
of	NULL
complex	NULL
I	NULL
in	NULL
RARE-mediated	NULL
transcription	NULL
is	NULL
unclear	NULL
.	NULL

Apparently	NULL
,	NULL
complex	NULL
II	NULL
!	NULL

(	NULL
VDR/RXR	NULL
)	NULL
did	NULL
not	NULL
activate	NULL
the	NULL
B-RARE	NULL
after	NULL
VitD3	NULL
stimulation	NULL
.	NULL

Nevertheless	NULL
,	NULL
after	NULL
stimulation	NULL
of	NULL
U-937	NULL
cells	NULL
with	NULL
VitD3	NULL
and	NULL
RA	NULL
,	NULL
transcriptional	NULL
activation	NULL
via	NULL
VDOR/RXR	NULL
would	NULL
be	NULL
possible	NULL
if	NULL
the	NULL
complex	NULL
bound	NULL
the	NULL
B-RARE	NULL
in	NULL
a	NULL
conformation	NULL
allowing	NULL
transactivation	NULL
to	NULL
occur	NULL
from	NULL
the	NULL
RXR	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
needed	NULL
to	NULL
clarify	NULL
how	NULL
RARE-mediated	NULL
transcription	NULL
is	NULL
regulated	NULL
during	NULL
combined	NULL
RA	NULL
and	NULL
VitD3	NULL
treatment	NULL
.	NULL

Also	NULL
,	NULL
the	NULL
biological	NULL
significance	NULL
of	NULL
the	NULL
VitD3-induced	NULL
changes	NULL
in	NULL
B-RARE	NULL
DNA	NULL
binding	NULL
remains	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

CD23	NULL
and	NULL
CD49f	NULL
gene	NULL
expression	NULL
,	NULL
characteristic	NULL
of	NULL
terminal	NULL
retinoid-induced	NULL
U-937	NULL
cell	NULL
differentiation	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
,	NULL
was	NULL
suppressed	NULL
by	NULL
VitD3	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
these	NULL
genes	NULL
did	NULL
not	NULL
seem	NULL
to	NULL
be	NULL
due	NULL
to	NULL
suppression	NULL
of	NULL
RARE-mediated	NULL
transcription	NULL
,	NULL
because	NULL
neither	NULL
RARE	NULL
reporter	NULL
activity	NULL
nor	NULL
RAR-B	NULL
expression	NULL
was	NULL
down-regulated	NULL
by	NULL
VitD3	NULL
stimulation	NULL
.	NULL

Instead	NULL
,	NULL
the	NULL
antagonism	NULL
between	NULL
RA	NULL
and	NULL
VitD3	NULL
in	NULL
terms	NULL
of	NULL
CD49f	NULL
and	NULL
CD23	NULL
regulation	NULL
might	NULL
result	NULL
from	NULL
effects	NULL
on	NULL
other	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Such	NULL
interference	NULL
between	NULL
RA-	NULL
and	NULL
VitD3-induced	NULL
events	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
monocytic	NULL
differentiation	NULL
process	NULL
could	NULL
involve	NULL
modulation	NULL
of	NULL
cytoplasmic	NULL
PKC	NULL
activity	NULL
(	NULL
42	NULL
)	NULL
or	NULL
interactions	NULL
between	NULL
the	NULL
VDR	NULL
and	NULL
RAR	NULL
complexes	NULL
and	NULL
other	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
AP-1	NULL
,	NULL
Spi-1/PU-1	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
43-45	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
imply	NULL
a	NULL
complex	NULL
role	NULL
for	NULL
VitD3	NULL
during	NULL
U-937	NULL
differentiation	NULL
.	NULL

VitD3	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
expression	NULL
of	NULL
RARE-regulated	NULL
genes	NULL
such	NULL
as	NULL
RAR-B	NULL
,	NULL
whereas	NULL
it	NULL
inhibited	NULL
the	NULL
expression	NULL
of	NULL
other	NULL
RA-regulated	NULL
genes	NULL
by	NULL
as	NULL
yet	NULL
unknown	NULL
mechanisms	NULL
.	NULL

VitD3	NULL
and	NULL
RA	NULL
together	NULL
up-regulated	NULL
CD14	NULL
and	NULL
RAR-B	NULL
expression	NULL
,	NULL
indicating	NULL
that	NULL
both	NULL
VitD3-	NULL
and	NULL
RA-stimulated	NULL
characteristics	NULL
could	NULL
be	NULL
induced	NULL
in	NULL
U-937	NULL
cells	NULL
after	NULL
co-stimulation	NULL
.	NULL

The	NULL
basis	NULL
for	NULL
this	NULL
additive	NULL
effect	NULL
would	NULL
thus	NULL
be	NULL
that	NULL
both	NULL
RARE-	NULL
and	NULL
VDRE-mediated	NULL
transcriptional	NULL
activity	NULL
was	NULL
maintained	NULL
in	NULL
U-937	NULL
cells	NULL
during	NULL
combined	NULL
VitD3	NULL
and	NULL
RA	NULL
treatment	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
antagonism	NULL
between	NULL
VitD3	NULL
and	NULL
RA	NULL
was	NULL
also	NULL
noted	NULL
,	NULL
both	NULL
at	NULL
the	NULL
level	NULL
of	NULL
RARE	NULL
DNA-binding	NULL
activity	NULL
and	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
CD23	NULL
and	NULL
CD49f	NULL
.	NULL

Consequently	NULL
,	NULL
VitD3	NULL
and	NULL
RA	NULL
displayed	NULL
both	NULL
additive	NULL
and	NULL
antagonistic	NULL
effects	NULL
on	NULL
U-937	NULL
cell	NULL
differentiation	NULL
.	NULL

This	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
in	NULL
other	NULL
hematopoietic	NULL
cell	NULL
systems	NULL
(	NULL
46-48	NULL
)	NULL
.	NULL

The	NULL
results	NULL
have	NULL
implications	NULL
for	NULL
the	NULL
use	NULL
of	NULL
retinoids	NULL
and	NULL
VitD3	NULL
in	NULL
the	NULL
clinical	NULL
setting	NULL
.	NULL

First	NULL
,	NULL
VitD3	NULL
is	NULL
a	NULL
potential	NULL
modulator	NULL
of	NULL
RA-induced	NULL
effects	NULL
in	NULL
differentiation	NULL
therapy	NULL
of	NULL
leukemias	NULL
,	NULL
but	NULL
it	NULL
could	NULL
possibly	NULL
antagonize	NULL
some	NULL
of	NULL
the	NULL
wanted	NULL
effects	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
Second	NULL
,	NULL
it	NULL
is	NULL
obvious	NULL
from	NULL
this	NULL
and	NULL
other	NULL
studies	NULL
that	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
classic	NULL
promoter	NULL
RAREs	NULL
does	NULL
not	NULL
altogether	NULL
reflect	NULL
the	NULL
biological	NULL
effects	NULL
of	NULL
retinoids	NULL
.	NULL

This	NULL
might	NULL
be	NULL
important	NULL
to	NULL
consider	NULL
when	NULL
evaluating	NULL
the	NULL
therapeutic	NULL
potential	NULL
of	NULL
new	NULL
retinoids	NULL
and	NULL
vitamin	NULL
D	NULL
compounds	NULL
.	NULL

A	NULL
deeper	NULL
knowledge	NULL
of	NULL
the	NULL
DNA-binding	NULL
and	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
RA	NULL
and	NULL
VitD3	NULL
receptors	NULL
in	NULL
hematopoietic	NULL
cells	NULL
is	NULL
vital	NULL
for	NULL
dissection	NULL
of	NULL
the	NULL
differentiation	NULL
signals	NULL
that	NULL
induce	NULL
terminal	NULL
differentiation	NULL
and	NULL
growth	NULL
arrest	NULL
in	NULL
such	NULL
cell	NULL
types	NULL
and	NULL
for	NULL
optimal	NULL
exploitation	NULL
of	NULL
RA	NULL
and	NULL
VitD3	NULL
as	NULL
therapeutic	NULL
agents	NULL
in	NULL
hematopoietic	NULL
tumors	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cells	NULL
.	NULL

The	NULL
U-937-1	NULL
subline	NULL
has	NULL
been	NULL
extensively	NULL
studied	NULL
in	NULL
our	NULL
laboratory	NULL
and	NULL
responds	NULL
faithfully	NULL
and	NULL
reproducibly	NULL
to	NULL
RA	NULL
and	NULL
VitD3	NULL
by	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
(	NULL
19	NULL
,	NULL
22	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
,	NULL
Uxbridge	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
and	NULL
antibiotics	NULL
(	NULL
100	NULL
units/ml	NULL
penicillin	NULL
and	NULL
50	NULL
ug/ml	NULL
streptomycin	NULL
}	NULL
.	NULL

Induction	NULL
of	NULL
Differentiation	NULL
.	NULL

Cells	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
0.2	NULL
x	NULL
10°/ml	NULL
were	NULL
exposed	NULL
to	NULL
0.1	NULL
um	NULL
VitD3	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
U.	NULL
Fischer	NULL
,	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Inc.	NULL
,	NULL
Basel	NULL
,	NULL
Switzerland	NULL
)	NULL
,	NULL
1.0	NULL
um	NULL
at-RA	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
0.1	NULL
or	NULL
1.0	NULL
wm	NULL
9cis-RA	NULL
(	NULL
Hoffmann-La	NULL
Roche	NULL
)	NULL
,	NULL
and	NULL
10	NULL
nm	NULL
PMA	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

The	NULL
doses	NULL
of	NULL
differentiating	NULL
agents	NULL
used	NULL
in	NULL
this	NULL
article	NULL
were	NULL
based	NULL
on	NULL
dose-response	NULL
experiments	NULL
performed	NULL
previously	NULL
,	NULL
testing	NULL
the	NULL
biological	NULL
response	NULL
of	NULL
these	NULL
agents	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

These	NULL
concentrations	NULL
of	NULL
RA	NULL
and	NULL
VitD3	NULL
are	NULL
optimal	NULL
for	NULL
induction	NULL
of	NULL
differentiation	NULL
of	NULL
U-937	NULL
cells	NULL
and	NULL
represent	NULL
doses	NULL
at	NULL
which	NULL
functional	NULL
interference	NULL
takes	NULL
place	NULL
in	NULL
U-937	NULL
cells	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
U-937-1	NULL
cells	NULL
was	NULL
performed	NULL
in	NULL
tissue	NULL
culture	NULL
flasks	NULL
precoated	NULL
with	NULL
agarose	NULL
M	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
to	NULL
prevent	NULL
adhesion	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

Successful	NULL
differentiation	NULL
was	NULL
defined	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
CD11c	NULL
(	NULL
LeuM5	NULL
;	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
by	NULL
growth	NULL
arrest	NULL
in	NULL
G	NULL
,	NULL
-G	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
23	NULL
)	NULL
.	NULL

We	NULL
also	NULL
analyzed	NULL
the	NULL
RA-specific	NULL
differentiation	NULL
markers	NULL
CD23	NULL
and	NULL
CD49f	NULL
and	NULL
the	NULL
VitD3-specific	NULL
expression	NULL
of	NULL
CD14	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

RNA	NULL
Analysis	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
prepared	NULL
for	NULL
Northern	NULL
blot	NULL
analysis	NULL
as	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Polyadenylated	NULL
RNA	NULL
was	NULL
obtained	NULL
through	NULL
oligodeoxythymidylic	NULL
acid	NULL
column	NULL
separation	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Hybridizations	NULL
were	NULL
performed	NULL
with	NULL
°°P-labeled	NULL
probes	NULL
(	NULL
Megaprime	NULL
DNA	NULL
labeling	NULL
systems	NULL
;	NULL
Amersham	NULL
,	NULL
Buckinghamshire	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
using	NULL
an	NULL
EcoR	NULL
!	NULL

fragment	NULL
of	NULL
the	NULL
CD49f	NULL
cDNA	NULL
(	NULL
50	NULL
)	NULL
,	NULL
a	NULL
Sstl-Xhol	NULL
fragment	NULL
of	NULL
the	NULL
CD14	NULL
cDNA	NULL
(	NULL
51	NULL
)	NULL
,	NULL
a	NULL
Pstl-BamHI	NULL
fragment	NULL
of	NULL
the	NULL
CD23	NULL
cDNA	NULL
pFceRII	NULL
(	NULL
52	NULL
)	NULL
,	NULL
an	NULL
EcoR	NULL
!	NULL

fragment	NULL
of	NULL
the	NULL
VDR	NULL
cDNA	NULL
clone	NULL
pH13	NULL
{	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Rock-ville	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
a	NULL
KpnI-EcoRl	NULL
fragment	NULL
of	NULL
the	NULL
RAR-a	NULL
«	NULL
cDNA	NULL
clone	NULL
p63	NULL
(	NULL
Amer-ican	NULL
Type	NULL
Culture	NULL
Collection	NULL
)	NULL
,	NULL
an	NULL
excised	NULL
PCR	NULL
fragment	NULL
of	NULL
RAR-8	NULL
transcript	NULL
nucleotides	NULL
862-1630	NULL
,	NULL
EcoRI	NULL
fragments	NULL
of	NULL
mouse	NULL
RXR-	NULL
«	NULL
and	NULL
-B	NULL
cDNAs	NULL
(	NULL
53	NULL
)	NULL
,	NULL
and	NULL
a	NULL
Pstl	NULL
fragment	NULL
of	NULL
the	NULL
mouse	NULL
«	NULL
-actin	NULL
cDNA	NULL
clone	NULL
p91	NULL
(	NULL
54	NULL
)	NULL
.	NULL

Nuclear	NULL
Extracts	NULL
and	NULL
EMSAs	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
55	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
50-100	NULL
x	NULL
10°	NULL
ceils	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
twice	NULL
in	NULL
cold	NULL
PBS	NULL
,	NULL
and	NULL
suspended	NULL
in	NULL
hypotonic	NULL
buffer	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
lysed	NULL
in	NULL
a	NULL
Dounce	NULL
homogenizer	NULL
(	NULL
type	NULL
B	NULL
pestle	NULL
)	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
and	NULL
suspended	NULL
in	NULL
high-salt	NULL
extraction	NULL
buffer	NULL
and	NULL
gently	NULL
sheared	NULL
through	NULL
a	NULL
0.6-mm	NULL
syringe	NULL
.	NULL

After	NULL
centrifugation	NULL
,	NULL
the	NULL
supernatant	NULL
was	NULL
dialyzed	NULL
on	NULL
microdialysis	NULL
filters	NULL
(	NULL
0,025	NULL
um	NULL
;	NULL
Millipore	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
}	NULL
,	NULL
and	NULL
the	NULL
extracts	NULL
were	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
in	NULL
aliquots	NULL
.	NULL

The	NULL
following	NULL
oligonucleotides	NULL
were	NULL
used	NULL
(	NULL
one	NULL
strand	NULL
shown	NULL
,	NULL
5'-3	NULL
'	NULL
;	NULL
added	NULL
Bgfl/BamHI	NULL
overhangs	NULL
are	NULL
in	NULL
lower	NULL
case	NULL
letters	NULL
)	NULL
:	NULL
the	NULL
osteocalcin	NULL
promoter	NULL
VDRE	NULL
(	NULL
OC-VDRE	NULL
,	NULL
gatctGGGGTGACT-CACCGGGTGAACGGGGGCATCg	NULL
;	NULL
Ref	NULL
.	NULL

13	NULL
)	NULL
;	NULL
a	NULL
synthetic	NULL
DR-3	NULL
VDRE	NULL
(	NULL
AGCTTCAGGTCAAGGAGGTCAGAGAGCT	NULL
;	NULL
Ref	NULL
.	NULL

10	NULL
)	NULL
;	NULL
the	NULL
RAR-B	NULL
,	NULL
promoter	NULL
RARE	NULL
(	NULL
B-RARE	NULL
,	NULL
gatctGGTAGGGTTACCCGAAAGTTCACTCGCg	NULL
;	NULL
Ref	NULL
.	NULL

56	NULL
)	NULL
;	NULL
a	NULL
synthetic	NULL
DR-2	NULL
(	NULL
gatctGGTAGGGTTCAGAAGTTCACTCGCg	NULL
;	NULL
Ref	NULL
.	NULL

57	NULL
)	NULL
;	NULL
the	NULL
everted	NULL
repeat	NULL
type	NULL
RARE	NULL
from	NULL
the	NULL
mouse	NULL
yF-crystallin	NULL
promoter	NULL
(	NULL
gatctGTGACCCTTTTAACCAGGTCAGTg	NULL
;	NULL
Ref	NULL
.	NULL

28	NULL
)	NULL
;	NULL
the	NULL
positive	NULL
regulatory	NULL
domain	NULL
I	NULL
from	NULL
the	NULL
8B	NULL
,	NULL
-IFN	NULL
promoter	NULL
(	NULL
PRDI	NULL
;	NULL
GAGAAGTGAAAGT-GGGAAATTCCT	NULL
;	NULL
Ref	NULL
.	NULL

58	NULL
)	NULL
;	NULL
and	NULL
an	NULL
AP-1	NULL
binding	NULL
site	NULL
(	NULL
gatcTCTTGATGAGT-CAGCCg	NULL
)	NULL
.	NULL

The	NULL
response	NULL
elements	NULL
were	NULL
labeled	NULL
either	NULL
by	NULL
5'-end	NULL
labeling	NULL
with	NULL
[	NULL
y®°P-ATP	NULL
]	NULL
of	NULL
the	NULL
corresponding	NULL
single-stranded	NULL
oligonucleotides	NULL
before	NULL
annealing	NULL
(	NULL
49	NULL
)	NULL
or	NULL
by	NULL
a	NULL
filling-in	NULL
reaction	NULL
with	NULL
[	NULL
°°PIdCTP	NULL
of	NULL
the	NULL
overhangs	NULL
after	NULL
annealing	NULL
(	NULL
Megaprime	NULL
DNA	NULL
labeling	NULL
systems	NULL
;	NULL
Amersham	NULL
)	NULL
.	NULL

The	NULL
DNA-binding	NULL
reactions	NULL
[	NULL
20	NULL
Ll	NULL
;	NULL
10	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
50	NULL
mm	NULL
KCI	NULL
,	NULL
5	NULL
mm	NULL
MgC	NULL
!	NULL

z	NULL
,	NULL
0,6	NULL
mm	NULL
DTT	NULL
,	NULL
2	NULL
ug	NULL
poly	NULL
(	NULL
dldC	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
20	NULL
ug	NULL
nuclear	NULL
extract	NULL
,	NULL
and	NULL
50,000	NULL
cpm	NULL
labeled	NULL
oligonucleotides	NULL
]	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
and	NULL
then	NULL
loaded	NULL
on	NULL
a	NULL
prerun	NULL
gel	NULL
(	NULL
4-5	NULL
%	NULL
polyacrylamide	NULL
in	NULL
Vax	NULL
Tris-borate	NULL
EDTA	NULL
)	NULL
in	NULL
%	NULL
&	NULL
x	NULL
Tris-borate	NULL
EDTA	NULL
buffer	NULL
for	NULL
electrophoresis	NULL
at	NULL
200-300	NULL
V.	NULL
Finally	NULL
,	NULL
the	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
retarded	NULL
protein-DNA	NULL
complexes	NULL
was	NULL
examined	NULL
by	NULL
competition	NULL
with	NULL
related	NULL
and	NULL
unrelated	NULL
oligonucleotides	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

Supershift	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
anti-VDR	NULL
(	NULL
a-hVDR-103	NULL
;	NULL
Ref	NULL
59	NULL
)	NULL
,	NULL
and	NULL
anti-RAR-	NULL
«	NULL
(	NULL
Qa-9A6	NULL
)	NULL
,	NULL
anti-RAR-8	NULL
(	NULL
6B-2A10	NULL
)	NULL
,	NULL
and	NULL
anti-RXR	NULL
(	NULL
4RX-1D12	NULL
,	NULL
recognizes	NULL
all	NULL
RXR	NULL
subspecies	NULL
)	NULL
,	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
P.	NULL
Chambon	NULL
(	NULL
(	NULL
GBMC	NULL
,	NULL
llikrich	NULL
,	NULL
France	NULL
;	NULL
Refs	NULL
.	NULL

57	NULL
and	NULL
60	NULL
)	NULL
.	NULL

Transfections	NULL
and	NULL
CAT	NULL
Assays	NULL
.	NULL

Reporter	NULL
plasmids	NULL
were	NULL
constructed	NULL
by	NULL
cloning	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
response	NULL
element	NULL
,	NULL
in	NULL
5-3	NULL
'	NULL
orientation	NULL
,	NULL
into	NULL
the	NULL
Bgill	NULL
site	NULL
upstream	NULL
of	NULL
the	NULL
SV40	NULL
promoter	NULL
in	NULL
the	NULL
pCAT	NULL
promoter	NULL
plasmid	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
}	NULL
.	NULL

The	NULL
reporter	NULL
constructs	NULL
were	NULL
designated	NULL
OC-VDREpCAT	NULL
,	NULL
B-RAREpCAT	NULL
,	NULL
and	NULL
DR-2pCAT	NULL
.	NULL

Twenty	NULL
million	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
suspended	NULL
in	NULL
a	NULL
cuvette	NULL
in	NULL
0.5	NULL
ml	NULL
RPMI	NULL
1640	NULL
containing	NULL
5-10	NULL
ug	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
a	NULL
CMV	NULL
promoter-driven	NULL
luciferase	NULL
vector	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
J.	NULL
Lucher-Firzlaff	NULL
,	NULL
Mediz-inische	NULL
Hochschule	NULL
,	NULL
Hannover	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
and	NULL
50	NULL
ug	NULL
carrier	NULL
DNA	NULL
(	NULL
salmon	NULL
testes	NULL
DNA	NULL
;	NULL
Sigma	NULL
)	NULL
.	NULL

After	NULL
electroporation	NULL
at	NULL
0.30	NULL
kV/960	NULL
microfarads	NULL
(	NULL
Gene	NULL
Pulser	NULL
;	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
the	NULL
cuvettes	NULL
were	NULL
left	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
transferred	NULL
to	NULL
culture	NULL
medium	NULL
.	NULL

To	NULL
ensure	NULL
identical	NULL
transfection	NULL
efficiency	NULL
in	NULL
cells	NULL
subjected	NULL
to	NULL
different	NULL
stimulation	NULL
protocols	NULL
,	NULL
multiple	NULL
cell	NULL
transfections	NULL
with	NULL
the	NULL
same	NULL
CAT	NULL
reporter	NULL
construct	NULL
were	NULL
pooled	NULL
for	NULL
recovery	NULL
in	NULL
the	NULL
incubator	NULL
for	NULL
2-4	NULL
h.	NULL
The	NULL
cell	NULL
pool	NULL
was	NULL
then	NULL
split	NULL
and	NULL
stimulated	NULL
with	NULL
RA	NULL
and	NULL
VitD3	NULL
as	NULL
described	NULL
above	NULL
.	NULL

After	NULL
overnight	NULL
treatment	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
suspended	NULL
in	NULL
0.25	NULL
m	NULL
Tris	NULL
buffer	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
obtained	NULL
by	NULL
three	NULL
cycles	NULL
of	NULL
freezing	NULL
and	NULL
thawing	NULL
and	NULL
heat	NULL
inactivated	NULL
,	NULL
and	NULL
finally	NULL
,	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
(	NULL
49	NULL
)	NULL
.	NULL

The	NULL
CAT	NULL
activity	NULL
was	NULL
quantified	NULL
by	NULL
measurement	NULL
of	NULL
the	NULL
amount	NULL
of	NULL
acetylated	NULL
[	NULL
'*CJchloramphenicol	NULL
in	NULL
an	NULL
image	NULL
analyzer	NULL
(	NULL
BAS2000	NULL
;	NULL
Fuji	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

On	NULL
a	NULL
portion	NULL
of	NULL
each	NULL
cell	NULL
pool	NULL
transfected	NULL
with	NULL
a	NULL
different	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
,	NULL
a	NULL
luciferase	NULL
assay	NULL
was	NULL
performed	NULL
(	NULL
61	NULL
)	NULL
.	NULL

This	NULL
allowed	NULL
comparison	NULL
of	NULL
CAT	NULL
activities	NULL
between	NULL
cells	NULL
transfected	NULL
with	NULL
different	NULL
CAT	NULL
constructs	NULL
.	NULL

Acknowledgments	NULL
We	NULL
are	NULL
grateful	NULL
for	NULL
the	NULL
excellent	NULL
technical	NULL
assistance	NULL
of	NULL
Inger	NULL
Karlberg	NULL
,	NULL
and	NULL
we	NULL
thank	NULL
Dr.	NULL
P.	NULL
Chambon	NULL
for	NULL
the	NULL
kind	NULL
gift	NULL
of	NULL
antibodies	NULL
directed	NULL
to	NULL
RAR	NULL
and	NULL
RXR	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Labbaye	NULL
,	NULL
C.	NULL
,	NULL
Vaitieri	NULL
,	NULL
M.	NULL
,	NULL
Testa	NULL
,	NULL
U.	NULL
,	NULL
Giampaolo	NULL
,	NULL
A.	NULL
,	NULL
Meccia	NULL
,	NULL
E.	NULL
,	NULL
Sterpetti	NULL
,	NULL
P.	NULL
,	NULL
Parolini	NULL
,	NULL
I.	NULL
,	NULL
Pelosi	NULL
,	NULL
E.	NULL
,	NULL
Bulgarini	NULL
,	NULL
D.	NULL
,	NULL
Cayre	NULL
,	NULL
Y.	NULL
E.	NULL
,	NULL
and	NULL
Peschle	NULL
,	NULL
C.	NULL
Retinoic	NULL
acid	NULL
downmodulates	NULL
erythroid	NULL
differentiation	NULL
and	NULL
GATA1	NULL
expression	NULL
in	NULL
purified	NULL
adult-progenitor	NULL
culture	NULL
.	NULL

Blood	NULL
,	NULL
83	NULL
:	NULL
651-656	NULL
,	NULL
1994	NULL
.	NULL

2	NULL
.	NULL

Tsai	NULL
,	NULL
S.	NULL
,	NULL
Bartelmez	NULL
,	NULL
S.	NULL
,	NULL
Sitnicka	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Collins	NULL
,	NULL
S.	NULL
Lymphohemato-poietic	NULL
progenitors	NULL
immortalized	NULL
by	NULL
a	NULL
retroviral	NULL
vector	NULL
harboring	NULL
a	NULL
domi-nant-negative	NULL
retinoic	NULL
acid	NULL
receptor	NULL
can	NULL
recapitulate	NULL
lymphoid	NULL
,	NULL
myeloid	NULL
,	NULL
and	NULL
erythroid	NULL
development	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
8	NULL
:	NULL
2831-2841	NULL
,	NULL
1994	NULL
.	NULL

3	NULL
.	NULL

Degos	NULL
,	NULL
L.	NULL
,	NULL
Dombret	NULL
,	NULL
H.	NULL
,	NULL
Chomienne	NULL
,	NULL
C.	NULL
,	NULL
Daniel	NULL
,	NULL
M-T.	NULL
,	NULL
Micléa	NULL
,	NULL
J-M.	NULL
,	NULL
Chastang	NULL
,	NULL
C.	NULL
,	NULL
Castaigne	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Fenaux	NULL
,	NULL
P.	NULL
All-trans	NULL
retinoic	NULL
acid	NULL
as	NULL
a	NULL
differentiating	NULL
agent	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

Blood	NULL
,	NULL
85	NULL
:	NULL
2643-2653	NULL
,	NULL
1995	NULL
.	NULL

4	NULL
.	NULL

Rigby	NULL
,	NULL
W.	NULL
F.	NULL
C.	NULL
The	NULL
immunobiclogy	NULL
of	NULL
vitamin	NULL
D.	NULL
Immunol	NULL
.	NULL

Today	NULL
,	NULL
9	NULL
:	NULL
54-58	NULL
,	NULL
1988	NULL
.	NULL

5	NULL
.	NULL

Nilsson	NULL
,	NULL
K.	NULL
,	NULL
Ivhed	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Forsbick	NULL
,	NULL
K.	NULL
Induced	NULL
differentiation	NULL
in	NULL
human	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
.	NULL

/n	NULL
:	NULL
L.	NULL
C.	NULL
Andersson	NULL
,	NULL
C.	NULL
G.	NULL
Gahmberg	NULL
,	NULL
and	NULL
P.	NULL
Ekblom	NULL
(	NULL
eds	NULL
.	NULL
)	NULL

,	NULL
Gene	NULL
Expression	NULL
during	NULL
Normal	NULL
and	NULL
Malignant	NULL
Differentiation	NULL
,	NULL
pp	NULL
.	NULL

57-72	NULL
.	NULL

London	NULL
:	NULL
Academic	NULL
Press	NULL
,	NULL
1985	NULL
.	NULL

6	NULL
.	NULL

Liibbert	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Koeffler	NULL
,	NULL
H.	NULL
P.	NULL
Leukemic	NULL
cell	NULL
lines	NULL
as	NULL
a	NULL
paradigm	NULL
for	NULL
myeloid	NULL
differentiation	NULL
.	NULL

Cancer	NULL
Rev	NULL
.	NULL

,	NULL
10	NULL
:	NULL
33-62	NULL
,	NULL
1988	NULL
.	NULL

1247	NULL
1248	NULL
VDR	NULL
,	NULL
RAR	NULL
,	NULL
and	NULL
RXR	NULL
Interactions	NULL
in	NULL
U-937	NULL
Cells	NULL
7	NULL
.	NULL

Chambon	NULL
,	NULL
P.	NULL
The	NULL
retinoid	NULL
signaling	NULL
pathway	NULL
:	NULL
molecular	NULL
and	NULL
genetic	NULL
analyses	NULL
.	NULL

Semin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
5	NULL
:	NULL
115-125	NULL
,	NULL
1994	NULL
.	NULL

8	NULL
.	NULL

Giguére	NULL
,	NULL
V.	NULL
Retinoic	NULL
acid	NULL
receptors	NULL
and	NULL
cellular	NULL
retinoid	NULL
binding	NULL
pro-teins	NULL
:	NULL
complex	NULL
interplay	NULL
in	NULL
retinoid	NULL
signaling	NULL
.	NULL

Endocr	NULL
.	NULL

Rev	NULL
.	NULL

,	NULL
15	NULL
:	NULL
61-79	NULL
,	NULL
1994	NULL
.	NULL

9	NULL
.	NULL

N	NULL
&	NULL
#	NULL
r	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Boutin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Lipkin	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Yu	NULL
,	NULL
V.	NULL
C.	NULL
,	NULL
Holloway	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Glass	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
and	NULL
Rosenfeld	NULL
,	NULL
M.	NULL
G.	NULL
The	NULL
orientation	NULL
and	NULL
spacing	NULL
of	NULL
core	NULL
DNA-binding	NULL
motifs	NULL
dictate	NULL
selective	NULL
transcriptional	NULL
responses	NULL
to	NULL
three	NULL
nuclear	NULL
receptors	NULL
.	NULL

Cell	NULL
,	NULL
65	NULL
:	NULL
1267-1279	NULL
,	NULL
1991	NULL
.	NULL

10	NULL
.	NULL

Umesono	NULL
,	NULL
K.	NULL
,	NULL
Murakami	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
Thompson	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
Direct	NULL
repeats	NULL
as	NULL
selective	NULL
response	NULL
elements	NULL
for	NULL
the	NULL
thyroid	NULL
hormone	NULL
,	NULL
retinoic	NULL
acid	NULL
,	NULL
and	NULL
vitamin	NULL
D3	NULL
receptors	NULL
.	NULL

Cell	NULL
,	NULL
65	NULL
:	NULL
1255-1266	NULL
,	NULL
1991	NULL
.	NULL

11	NULL
.	NULL

Yu	NULL
,	NULL
V.	NULL
C.	NULL
,	NULL
Detsert	NULL
,	NULL
C.	NULL
,	NULL
Andersen	NULL
,	NULL
B.	NULL
,	NULL
Holloway	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Devary	NULL
,	NULL
O.	NULL
V.	NULL
,	NULL
Nair	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Kim	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
Boutin	NULL
,	NULL
J-M.	NULL
,	NULL
Glass	NULL
,	NULL
C.	NULL
K.	NULL
,	NULL
and	NULL
Rosenfeld	NULL
,	NULL
M.	NULL
G.	NULL
RXRB	NULL
:	NULL
a	NULL
coregulator	NULL
that	NULL
enhances	NULL
binding	NULL
of	NULL
retinoic	NULL
acid	NULL
,	NULL
thyroid	NULL
hormone	NULL
,	NULL
and	NULL
vitamin	NULL
D	NULL
receptors	NULL
to	NULL
their	NULL
cognate	NULL
response	NULL
elements	NULL
.	NULL

Cell	NULL
,	NULL
67	NULL
:	NULL
1251-1266	NULL
,	NULL
1991	NULL
.	NULL

12	NULL
.	NULL

Perlmann	NULL
,	NULL
T.	NULL
,	NULL
Rangarajan	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
Umesono	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
Determinants	NULL
for	NULL
selective	NULL
RAR	NULL
and	NULL
TR	NULL
recognition	NULL
of	NULL
direct	NULL
repeat	NULL
HREs	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
7	NULL
:	NULL
1411-1422	NULL
,	NULL
1993	NULL
.	NULL

13	NULL
.	NULL

Carlberg	NULL
,	NULL
C.	NULL
,	NULL
Bendick	NULL
,	NULL
I.	NULL
,	NULL
Wyss	NULL
,	NULL
A.	NULL
,	NULL
Meier	NULL
,	NULL
E.	NULL
,	NULL
Sturzenbecker	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Grippo	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
and	NULL
Hunziker	NULL
,	NULL
W.	NULL
Two	NULL
nuclear	NULL
signalling	NULL
pathways	NULL
for	NULL
vitamin	NULL
D.	NULL
Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
361	NULL
:	NULL
657-660	NULL
,	NULL
1993	NULL
.	NULL

14	NULL
.	NULL

Schrider	NULL
,	NULL
M.	NULL
,	NULL
Bendik	NULL
,	NULL
I.	NULL
,	NULL
Becker-André	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Carlberg	NULL
,	NULL
C.	NULL
Interaction	NULL
between	NULL
retinoic	NULL
acid	NULL
and	NULL
vitamin	NULL
D	NULL
signaling	NULL
pathways	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
268	NULL
:	NULL
17830-17836	NULL
,	NULL
1993	NULL
.	NULL

15	NULL
.	NULL

Schrader	NULL
,	NULL
M.	NULL
,	NULL
Muller	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Nayeri	NULL
,	NULL
S.	NULL
,	NULL
Kahlen	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
and	NULL
Carlberg	NULL
,	NULL
C.	NULL
Vitamin	NULL
D3-thyroid	NULL
hormone	NULL
receptor	NULL
heterodimer	NULL
polarity	NULL
directs	NULL
ligand	NULL
sensitivity	NULL
of	NULL
transactivation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
370	NULL
:	NULL
382-386	NULL
,	NULL
1994	NULL
.	NULL

16	NULL
.	NULL

Cooney	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Tsai	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
O'Malley	NULL
,	NULL
B.	NULL
W.	NULL
,	NULL
and	NULL
Tsai	NULL
,	NULL
M-J	NULL
.	NULL

Chicken	NULL
ovalbumin	NULL
upstream	NULL
promoter	NULL
transcription	NULL
factor	NULL
(	NULL
COUP-TF	NULL
)	NULL
dimers	NULL
bind	NULL
to	NULL
different	NULL
GGTCA	NULL
response	NULL
elements	NULL
,	NULL
allowing	NULL
COUP-TF	NULL
to	NULL
repress	NULL
hormonal	NULL
induction	NULL
of	NULL
the	NULL
vitamin	NULL
D3	NULL
,	NULL
thyroid	NULL
hormone	NULL
,	NULL
and	NULL
retinoic	NULL
acid	NULL
receptors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
;	NULL
4153-4163	NULL
,	NULL
1992	NULL
.	NULL

17	NULL
.	NULL

Cheskis	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Freedman	NULL
,	NULL
L.	NULL
P.	NULL
Ligand	NULL
modulates	NULL
the	NULL
conversion	NULL
of	NULL
DNA-bound	NULL
vitamin	NULL
D3	NULL
receptor	NULL
(	NULL
VDR	NULL
)	NULL
homodimers	NULL
into	NULL
VDR-retinoid	NULL
X	NULL
receptor	NULL
heterodimers	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
;	NULL
3329-3338	NULL
,	NULL
1994	NULL
.	NULL

18	NULL
.	NULL

MacDonald	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
Dowd	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Nakajima	NULL
,	NULL
S.	NULL
,	NULL
Galligan	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Reeder	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Haussler	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Ozato	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Haussler	NULL
,	NULL
M.	NULL
R.	NULL
Retinoid	NULL
X	NULL
receptors	NULL
stimulate	NULL
and	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
inhibits	NULL
1,25-dihydroxyvitamin	NULL
D3-acti-vated	NULL
expression	NULL
of	NULL
the	NULL
rat	NULL
osteocalcin	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
:	NULL
5907-5917	NULL
,	NULL
1993	NULL
.	NULL

19	NULL
.	NULL

Sundstrom	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Nilsson	NULL
,	NULL
K.	NULL
Establishment	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
human	NULL
histiocytic	NULL
lymphoma	NULL
cell	NULL
line	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
17	NULL
:	NULL
565-577	NULL
,	NULL
1976	NULL
.	NULL

20	NULL
.	NULL

Olsson	NULL
,	NULL
1	NULL
.	NULL

L.	NULL
,	NULL
and	NULL
Breitman	NULL
,	NULL
T.	NULL
R.	NULL
Induction	NULL
of	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
histiocytic	NULL
lymphoma	NULL
cell	NULL
line	NULL
U-937	NULL
by	NULL
retinoic	NULL
acid	NULL
and	NULL
cyclic	NULL
adenosine	NULL
3':5'-monophosphate-inducing	NULL
agents	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
42	NULL
:	NULL
3924-3927	NULL
,	NULL
1982	NULL
.	NULL

21	NULL
.	NULL

Olsson	NULL
,	NULL
I.	NULL
,	NULL
Gullberg	NULL
,	NULL
U.	NULL
,	NULL
ivhed	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Nilsson	NULL
,	NULL
K.	NULL
Induction	NULL
of	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
histiocytic	NULL
lymphoma	NULL
cell	NULL
line	NULL
U-937	NULL
by	NULL
1	NULL
«	NULL
,25-dihydroxycholecalciferol	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
43	NULL
:	NULL
5862-5867	NULL
,	NULL
1983	NULL
.	NULL

22	NULL
.	NULL

Oberg	NULL
,	NULL
F.	NULL
,	NULL
Botling	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Nilsson	NULL
,	NULL
K.	NULL
Functional	NULL
antagonism	NULL
between	NULL
vitamin	NULL
D3	NULL
and	NULL
retinoic	NULL
acid	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
CD14	NULL
and	NULL
CD23	NULL
expression	NULL
during	NULL
monocytic	NULL
differentiation	NULL
of	NULL
U-937	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
150	NULL
:	NULL
3487-3495	NULL
,	NULL
1993	NULL
.	NULL

23	NULL
.	NULL

Botling	NULL
,	NULL
J.	NULL
,	NULL
Oberg	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Nilsson	NULL
,	NULL
K.	NULL
CD49f	NULL
(	NULL
a6	NULL
integrin	NULL
)	NULL
and	NULL
CD66a	NULL
(	NULL
BGP	NULL
)	NULL
are	NULL
specifically	NULL
induced	NULL
by	NULL
retinoids	NULL
during	NULL
human	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Leukemia	NULL
,	NULL
9	NULL
:	NULL
2034-2041	NULL
,	NULL
1995	NULL
.	NULL

24	NULL
.	NULL

Haris	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Ralph	NULL
,	NULL
P.	NULL
Human	NULL
leukemic	NULL
models	NULL
of	NULL
myelomonocytic	NULL
development	NULL
:	NULL
a	NULL
review	NULL
of	NULL
the	NULL
HL-60	NULL
and	NULL
U937	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

,	NULL
37	NULL
:	NULL
407-422	NULL
,	NULL
1985	NULL
.	NULL

25	NULL
.	NULL

Hsieh	NULL
,	NULL
J-C.	NULL
,	NULL
Jurutka	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
Galligan	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Terpening	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Haussler	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Samuels	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Shimizu	NULL
,	NULL
Y.	NULL
,	NULL
Shimizu	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Haussler	NULL
,	NULL
M.	NULL
R.	NULL
Human	NULL
vitamin	NULL
D	NULL
receptor	NULL
is	NULL
selectively	NULL
phosphorylated	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
on	NULL
serine	NULL
51	NULL
,	NULL
a	NULL
residue	NULL
crucial	NULL
to	NULL
its	NULL
frans-activation	NULL
function	NULL
.	NULL

Proc	NULL
.	NULL

Natt	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
:	NULL
9315-9319	NULL
,	NULL
1991	NULL
.	NULL

26	NULL
.	NULL

Jones	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
,	NULL
Jurutka	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
Haussler	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Haussler	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Whitfield	NULL
,	NULL
G.	NULL
K.	NULL
Vitamin	NULL
D	NULL
receptor	NULL
phosphorylation	NULL
in	NULL
transfected	NULL
ROS	NULL
17/2.8	NULL
cells	NULL
is	NULL
localized	NULL
to	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
the	NULL
hormone-binding	NULL
domain	NULL
.	NULL

Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

,	NULL
5	NULL
:	NULL
1137-1146	NULL
,	NULL
1991	NULL
.	NULL

27	NULL
.	NULL

Oberg	NULL
,	NULL
F.	NULL
,	NULL
Larsson	NULL
,	NULL
L-G.	NULL
,	NULL
Anton	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Nilsson	NULL
,	NULL
K.	NULL
Interferon	NULL
y	NULL
abrogates	NULL
the	NULL
differentiation	NULL
block	NULL
in	NULL
v-myc-expressing	NULL
U-937	NULL
mono-blasts	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
:	NULL
5567-5571	NULL
,	NULL
1991	NULL
.	NULL

28	NULL
.	NULL

Tini	NULL
,	NULL
M.	NULL
,	NULL
Otulakowski	NULL
,	NULL
G.	NULL
,	NULL
Breitman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Tsui	NULL
,	NULL
L-C.	NULL
,	NULL
and	NULL
Giguere	NULL
,	NULL
V.	NULL
An	NULL
everted	NULL
repeat	NULL
mediates	NULL
retinoic	NULL
acid	NULL
induction	NULL
of	NULL
the	NULL
yF-crystallin	NULL
gene	NULL
:	NULL
evidence	NULL
of	NULL
a	NULL
direct	NULL
role	NULL
for	NULL
retinoids	NULL
in	NULL
lens	NULL
development	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
7	NULL
:	NULL
295-307	NULL
,	NULL
1993	NULL
.	NULL

29	NULL
.	NULL

Defaque	NULL
,	NULL
H.	NULL
,	NULL
Commes	NULL
,	NULL
T.	NULL
,	NULL
Sevilla	NULL
,	NULL
C.	NULL
,	NULL
Rochette-Egly	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Marti	NULL
,	NULL
J.	NULL
Synergistic	NULL
differentiation	NULL
of	NULL
U-937	NULL
cells	NULL
by	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
and	NULL
1a,25-dihydroxyvitamin	NULL
D3	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
retinoid	NULL
X	NULL
receptor	NULL
a.	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

,	NULL
203	NULL
:	NULL
272-280	NULL
,	NULL
1994	NULL
.	NULL

30	NULL
.	NULL

Sone	NULL
,	NULL
T.	NULL
,	NULL
Kerner	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Pike	NULL
,	NULL
J.	NULL
W.	NULL
Vitamin	NULL
D	NULL
receptor	NULL
interaction	NULL
with	NULL
specific	NULL
DNA	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
266	NULL
:	NULL
23296-23305	NULL
,	NULL
1991	NULL
.	NULL

31	NULL
.	NULL

Breen	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
van	NULL
Wijnen	NULL
,	NULL
A.	NULL
,	NULL
Lian	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Stein	NULL
,	NULL
G.	NULL
S.	NULL
,	NULL
and	NULL
Stein	NULL
,	NULL
J.	NULL
L.	NULL
In	NULL
vivo	NULL
occupancy	NULL
of	NULL
the	NULL
vitamin	NULL
D	NULL
responsive	NULL
element	NULL
in	NULL
the	NULL
osteocalcin	NULL
gene	NULL
supports	NULL
vitamin	NULL
D-dependent	NULL
transcriptional	NULL
upregulation	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natt	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
97	NULL
:	NULL
12902-12906	NULL
,	NULL
1994	NULL
.	NULL

32	NULL
.	NULL

Bortell	NULL
,	NULL
R.	NULL
,	NULL
Owen	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Shalhoub	NULL
,	NULL
V.	NULL
,	NULL
Heinrichs	NULL
,	NULL
A.	NULL
,	NULL
Aronow	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Rochette-Egly	NULL
,	NULL
C.	NULL
,	NULL
Lutz	NULL
,	NULL
Y.	NULL
,	NULL
Stein	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Lian	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Stein	NULL
,	NULL
G.	NULL
S.	NULL
Constitutive	NULL
transcription	NULL
of	NULL
the	NULL
osteocalcin	NULL
gene	NULL
in	NULL
osteosarcoma	NULL
cells	NULL
is	NULL
reflected	NULL
by	NULL
altered	NULL
protein-DNA	NULL
interactions	NULL
at	NULL
promoter	NULL
regulatory	NULL
elements	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
:	NULL
2300-2304	NULL
,	NULL
1993	NULL
.	NULL

33	NULL
.	NULL

Ross	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Darwish	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Moss	NULL
,	NULL
V.	NULL
E.	NULL
,	NULL
and	NULL
DeLuca	NULL
,	NULL
H.	NULL
F.	NULL
Vitamin	NULL
D-influenced	NULL
gene	NULL
expression	NULL
via	NULL
a	NULL
ligand	NULL
independent	NULL
,	NULL
receptor-DNA	NULL
intermediate	NULL
.	NULL

Proc	NULL
.	NULL

Nati	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
;	NULL
9257-9260	NULL
,	NULL
1993	NULL
.	NULL

34	NULL
.	NULL

Minucci	NULL
,	NULL
S.	NULL
,	NULL
Zand	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Dey	NULL
,	NULL
A.	NULL
,	NULL
Marks	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Nagata	NULL
,	NULL
T.	NULL
,	NULL
Grippo	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
and	NULL
Ozato	NULL
,	NULL
K.	NULL
Dominant	NULL
negative	NULL
retinoid	NULL
X	NULL
receptor	NULL
8	NULL
inhibits	NULL
retinoic	NULL
acid-responsive	NULL
gene	NULL
regulation	NULL
in	NULL
embryonal	NULL
carcinoma	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
:	NULL
360-372	NULL
,	NULL
1994	NULL
.	NULL

35	NULL
.	NULL

Xiao	NULL
,	NULL
J-H.	NULL
,	NULL
Durand	NULL
,	NULL
B.	NULL
,	NULL
Chambon	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Voorhees	NULL
,	NULL
J.	NULL
J.	NULL
Endogenous	NULL
retinoic	NULL
acid	NULL
receptor	NULL
(	NULL
RAR	NULL
)	NULL
-retinoid	NULL
X	NULL
receptors	NULL
(	NULL
RXR	NULL
)	NULL
heterodimers	NULL
are	NULL
the	NULL
major	NULL
functional	NULL
forms	NULL
regulating	NULL
retinoid-responsive	NULL
elements	NULL
in	NULL
adult	NULL
human	NULL
keratinocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
:	NULL
3001-3011	NULL
,	NULL
1995	NULL
.	NULL

36	NULL
.	NULL

Zelent	NULL
,	NULL
A.	NULL
,	NULL
Mendelsohn	NULL
,	NULL
C.	NULL
,	NULL
Kastner	NULL
,	NULL
P.	NULL
,	NULL
Krust	NULL
,	NULL
A.	NULL
,	NULL
Gamier	NULL
,	NULL
J-M.	NULL
,	NULL
Ruffenach	NULL
,	NULL
F.	NULL
,	NULL
Leroy	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Chambon	NULL
,	NULL
P.	NULL
Differentially	NULL
expressed	NULL
iso-forms	NULL
of	NULL
the	NULL
mouse	NULL
retinoic	NULL
acid	NULL
receptor	NULL
8	NULL
are	NULL
generated	NULL
by	NULL
usage	NULL
of	NULL
two	NULL
promoters	NULL
and	NULL
alternative	NULL
splicing	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
10	NULL
;	NULL
71-81	NULL
,	NULL
1991	NULL
.	NULL

37	NULL
.	NULL

Aoudjit	NULL
,	NULL
F.	NULL
,	NULL
Brochu	NULL
,	NULL
N.	NULL
,	NULL
Morin	NULL
,	NULL
N.	NULL
,	NULL
Poulin	NULL
,	NULL
G.	NULL
,	NULL
Stratowa	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Audette	NULL
,	NULL
M.	NULL
Heterodimeric	NULL
retinoic	NULL
acid	NULL
receptor-8	NULL
and	NULL
retinoid	NULL
X	NULL
recep-tor-a	NULL
complexes	NULL
stimulate	NULL
expression	NULL
of	NULL
the	NULL
intercellutar	NULL
adhesion	NULL
molecule-1	NULL
gene	NULL
.	NULL

Celt	NULL
Growth	NULL
&	NULL
Differ	NULL
.	NULL

,	NULL
6	NULL
:	NULL
515-521	NULL
,	NULL
1995	NULL
.	NULL

38	NULL
.	NULL

Seewaldt	NULL
,	NULL
V.	NULL
L.	NULL
,	NULL
Johnson	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
Parker	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Collins	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
Swisshelm	NULL
,	NULL
K.	NULL
Expression	NULL
of	NULL
retinoic	NULL
acid	NULL
receptor	NULL
B	NULL
mediates	NULL
retinoic	NULL
acid-induced	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
in	NULL
breast	NULL
cancer	NULL
cells	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differ	NULL
.	NULL

,	NULL
6	NULL
:	NULL
1077-1088	NULL
,	NULL
1995	NULL
.	NULL

39	NULL
.	NULL

Barettino	NULL
,	NULL
D.	NULL
,	NULL
Bugge	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
Bartunek	NULL
,	NULL
P.	NULL
,	NULL
Vivanco	NULL
Ruiz	NULL
,	NULL
M.	NULL
d.	NULL
M.	NULL
,	NULL
Sonntag-Buck	NULL
,	NULL
V.	NULL
,	NULL
Beug	NULL
,	NULL
H.	NULL
,	NULL
Zenke	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Stunnentberg	NULL
,	NULL
H.	NULL
G.	NULL
Unligan-ded	NULL
T3R	NULL
,	NULL
but	NULL
not	NULL
its	NULL
oncogenic	NULL
variant	NULL
,	NULL
v-erbA	NULL
,	NULL
suppresses	NULL
RAR-depend-ent	NULL
transactivation	NULL
by	NULL
titrating	NULL
out	NULL
RXR	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
12	NULL
;	NULL
1343-1354	NULL
,	NULL
1993	NULL
.	NULL

40	NULL
.	NULL

Lehmann	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Zhang	NULL
,	NULL
X-K.	NULL
,	NULL
Graupner	NULL
,	NULL
G.	NULL
,	NULL
Lee	NULL
,	NULL
M-O	NULL
.	NULL

,	NULL
Hermann	NULL
,	NULL
T.	NULL
,	NULL
Hoffman	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Pfahl	NULL
,	NULL
M.	NULL
Formation	NULL
of	NULL
retinoid	NULL
X	NULL
receptor	NULL
homodimers	NULL
leads	NULL
to	NULL
repression	NULL
of	NULL
T3	NULL
response	NULL
:	NULL
hormonal	NULL
crosstalk	NULL
by	NULL
ligand-induced	NULL
squelching	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
:	NULL
7698-7707	NULL
,	NULL
1993	NULL
.	NULL

41	NULL
.	NULL

HGrlein	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Heinzel	NULL
,	NULL
T.	NULL
,	NULL
Torchia	NULL
,	NULL
J.	NULL
,	NULL
Gloss	NULL
,	NULL
B.	NULL
,	NULL
Kurokawa	NULL
,	NULL
R.	NULL
,	NULL
Ryan	NULL
,	NULL
A.	NULL
,	NULL
Kamei	NULL
,	NULL
Y.	NULL
,	NULL
Sdderstrom	NULL
,	NULL
M.	NULL
,	NULL
Glass	NULL
,	NULL
C.	NULL
K.	NULL
,	NULL
and	NULL
Rosenfeld	NULL
,	NULL
M.	NULL
G.	NULL
Ligand-independent	NULL
repression	NULL
by	NULL
the	NULL
thyroid	NULL
hormone	NULL
receptor	NULL
mediated	NULL
by	NULL
a	NULL
nuclear	NULL
receptor	NULL
co-repressor	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
377	NULL
:	NULL
397-404	NULL
,	NULL
1995	NULL
.	NULL

42	NULL
.	NULL

Slater	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Kelly	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Taddeo	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
Larkin	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Yeager	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
McLane	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Ho	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Stubbs	NULL
,	NULL
C.	NULL
D.	NULL
Direct	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
by	NULL
1a,25-dihydroxyvitamin	NULL
D3	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
:	NULL
6639-6643	NULL
,	NULL
1995	NULL
.	NULL

43	NULL
.	NULL

Fanjut	NULL
,	NULL
A.	NULL
,	NULL
Dawson	NULL
,	NULL
M.	NULL
I.	NULL
,	NULL
Hobbs	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
Jong	NULL
,	NULL
L.	NULL
,	NULL
Cameron	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Harlev	NULL
,	NULL
E.	NULL
,	NULL
Graupner	NULL
,	NULL
G.	NULL
,	NULL
Lu	NULL
,	NULL
X-P.	NULL
,	NULL
and	NULL
Pfahl	NULL
,	NULL
M.	NULL
A	NULL
new	NULL
class	NULL
of	NULL
retinoids	NULL
with	NULL
selective	NULL
inhibition	NULL
of	NULL
AP-1	NULL
inhibits	NULL
proliferation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
372	NULL
:	NULL
107-111	NULL
,	NULL
1994	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
44	NULL
.	NULL

Gauthier	NULL
,	NULL
J-M.	NULL
,	NULL
Bourachot	NULL
,	NULL
B.	NULL
,	NULL
Doucas	NULL
,	NULL
V.	NULL
,	NULL
Yaniv	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Moreau-Gachelin	NULL
,	NULL
F.	NULL
Functional	NULL
interference	NULL
between	NULL
the	NULL
Spi-1/PU.1	NULL
oncoprotein	NULL
and	NULL
steroid	NULL
hormone	NULL
receptors	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
12	NULL
:	NULL
5089-5096	NULL
,	NULL
1993.	NULL
:	NULL
45	NULL
.	NULL

Segars	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Nagata	NULL
,	NULL
T.	NULL
,	NULL
Bours	NULL
,	NULL
V.	NULL
,	NULL
Medin	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Franzosm'hff	NULL
,	NULL
‘	NULL
Blanco	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Drew	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
Becker	NULL
,	NULL
K.	NULL
G.	NULL
,	NULL
An	NULL
,	NULL
J.	NULL
,	NULL
Tang	NULL
,	NULL
T.	NULL
,	NULL
Stephany	NULL
,	NULL
D.	NULL
A.	NULL
;	NULL
Neel	NULL
,	NULL
B.	NULL
,	NULL
Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Ozato	NULL
,	NULL
K.	NULL
Retinoic	NULL
acid	NULL
induction	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
I	NULL
genes	NULL
in	NULL
NTera-2	NULL
embryonal	NULL
carcinoma	NULL
cells	NULL
involves	NULL
induction	NULL
of	NULL
NF-kappa	NULL
B	NULL
(	NULL
pS50-p65	NULL
)	NULL
and	NULL
retinoic	NULL
Acid-re-ceptor	NULL
B-retinoid	NULL
X	NULL
receptor	NULL
B	NULL
heterodimers	NULL
.	NULL

Mot	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
:	NULL
6157-6169	NULL
,	NULL
1993	NULL
.	NULL

46	NULL
.	NULL

Masciulli	NULL
,	NULL
R.	NULL
,	NULL
Testa	NULL
,	NULL
U.	NULL
,	NULL
Barberi	NULL
,	NULL
T.	NULL
,	NULL
Samoggia	NULL
,	NULL
P.	NULL
,	NULL
Tritarelli	NULL
,	NULL
E.	NULL
,	NULL
Pustorino	NULL
,	NULL
R.	NULL
,	NULL
Mastroberardino	NULL
,	NULL
G.	NULL
,	NULL
Camagna	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Peschle	NULL
,	NULL
C.	NULL
Combined	NULL
vitamin	NULL
D3/retinoic	NULL
acid	NULL
induction	NULL
of	NULL
human	NULL
promyelocytic	NULL
cell	NULL
lines	NULL
:	NULL
enhanced	NULL
phagocytic	NULL
cell	NULL
maturation	NULL
and	NULL
hybrid	NULL
granulomonocytic	NULL
phenotype	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differ	NULL
.	NULL

,	NULL
6	NULL
:	NULL
493-503	NULL
,	NULL
1995	NULL
.	NULL

47	NULL
.	NULL

Brown	NULL
,	NULL
G.	NULL
,	NULL
Bunce	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Rowlands	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
and	NULL
Williams	NULL
,	NULL
G.	NULL
R.	NULL
All-trans	NULL
retinoic	NULL
acid	NULL
and	NULL
1a,25-dihydroxyvitamin	NULL
D3	NULL
co-operate	NULL
to	NULL
promote	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
promyeloid	NULL
leukemia	NULL
cell	NULL
line	NULL
HL6O	NULL
to	NULL
monocytes	NULL
.	NULL

Leukemia	NULL
(	NULL
Baltimore	NULL
)	NULL
,	NULL
8	NULL
:	NULL
806-815	NULL
,	NULL
1994	NULL
.	NULL

48	NULL
.	NULL

Woods	NULL
,	NULL
C.	NULL
,	NULL
Domenget	NULL
,	NULL
C.	NULL
,	NULL
Solari	NULL
,	NULL
F.	NULL
,	NULL
Gandrillon	NULL
,	NULL
O.	NULL
,	NULL
Lazarides	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Jurdic	NULL
,	NULL
P.	NULL
Antagonistic	NULL
role	NULL
of	NULL
vitamin	NULL
D3	NULL
and	NULL
retinoic	NULL
acid	NULL
on	NULL
the	NULL
differentiation	NULL
of	NULL
chicken	NULL
hematopoietic	NULL
macrophages	NULL
into	NULL
osteoclast	NULL
precursor	NULL
calls	NULL
.	NULL

Endocrinology	NULL
,	NULL
136	NULL
:	NULL
85-95	NULL
,	NULL
1995	NULL
.	NULL

49	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
:	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Labo-ratory	NULL
,	NULL
1989	NULL
.	NULL

50	NULL
.	NULL

Hogervorst	NULL
,	NULL
F.	NULL
,	NULL
Kuikman	NULL
,	NULL
I.	NULL
,	NULL
Van	NULL
Kessel	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
and	NULL
Sonnenberg	NULL
,	NULL
A.	NULL
Molecular	NULL
cloning	NULL
of	NULL
the	NULL
«	NULL
6	NULL
integrin	NULL
subunit	NULL
:	NULL
alternative	NULL
splicing	NULL
of	NULL
a6	NULL
mRNA	NULL
and	NULL
chromosomal	NULL
localisation	NULL
of	NULL
the	NULL
a6	NULL
and	NULL
B4	NULL
genes	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Bip-chem	NULL
.	NULL

,	NULL
199	NULL
;	NULL
425-433	NULL
,	NULL
1991	NULL
.	NULL

§1	NULL
.	NULL

Ferrero	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Goyert	NULL
,	NULL
S.	NULL
M.	NULL
Nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
monocyte	NULL
differentiation	NULL
antigen	NULL
,	NULL
CD14	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
16	NULL
:	NULL
4173	NULL
,	NULL
1988	NULL
.	NULL

52	NULL
.	NULL

Kikutani	NULL
,	NULL
H.	NULL
,	NULL
Inui	NULL
,	NULL
S.	NULL
,	NULL
Sato	NULL
,	NULL
R.	NULL
,	NULL
Barsumian	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
Owaki	NULL
,	NULL
H.	NULL
,	NULL
Yamasali	NULL
,	NULL
K.	NULL
,	NULL
Kaisho	NULL
,	NULL
T.	NULL
,	NULL
Uchibayashi	NULL
,	NULL
N.	NULL
,	NULL
Hardy	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Hirano	NULL
,	NULL
T.	NULL
,	NULL
Tsunasawa	NULL
,	NULL
S.	NULL
,	NULL
Sakiyama	NULL
,	NULL
F.	NULL
,	NULL
Suemura	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Kishimoto	NULL
,	NULL
T.	NULL
Molecular	NULL
structure	NULL
of	NULL
human	NULL
lymphocyte	NULL
receptor	NULL
for	NULL
immunoglobulin	NULL
E.	NULL
Cell	NULL
,	NULL
47	NULL
:	NULL
657-665	NULL
,	NULL
1986	NULL
.	NULL

53	NULL
.	NULL

Mangelsdort	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Borgmeyer	NULL
,	NULL
U.	NULL
,	NULL
Heyman	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Zhou	NULL
,	NULL
J.	NULL
Y.	NULL
,	NULL
Ong	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Oro	NULL
,	NULL
.	NULL

A	NULL
,	NULL
.	NULL

£	NULL
.	NULL

,	NULL
Kakizuka	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
Characterization	NULL
of	NULL
three	NULL
RXR	NULL
genes	NULL
that	NULL
mediate	NULL
the	NULL
action	NULL
of	NULL
9-c/s	NULL
retinoic	NULL
acid	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
6	NULL
:	NULL
329-344	NULL
,	NULL
1992	NULL
.	NULL

54	NULL
.	NULL

Minty	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Caravatti	NULL
,	NULL
M.	NULL
,	NULL
Robert	NULL
,	NULL
B.	NULL
,	NULL
Cohen	NULL
,	NULL
A.	NULL
,	NULL
Daubas	NULL
,	NULL
P.	NULL
,	NULL
Wyedert	NULL
,	NULL
A.	NULL
,	NULL
Gros	NULL
,	NULL
8.	NULL
,	NULL
and	NULL
Buckingham	NULL
,	NULL
M.	NULL
Mouse	NULL
messenger	NULL
RNAs	NULL
.	NULL

Construction	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
recombinant	NULL
plasmid	NULL
molecule	NULL
containing	NULL
a	NULL
complementary	NULL
DNA	NULL
transcript	NULL
of	NULL
mouse	NULL
a-actin	NULL
mRNA	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
256	NULL
:	NULL
1008-1014	NULL
,	NULL
1981	NULL
.	NULL

55	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
11	NULL
:	NULL
1475-1489	NULL
,	NULL
1983	NULL
.	NULL

56.	NULL
de	NULL
The	NULL
,	NULL
H.	NULL
,	NULL
Vivanco-Ruiz	NULL
,	NULL
M.	NULL
d.	NULL
M.	NULL
,	NULL
Tiollats	NULL
,	NULL
P.	NULL
,	NULL
Stunnenberg	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Dejean	NULL
,	NULL
A	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
retinoic	NULL
acid	NULL
responsive	NULL
element	NULL
in	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor	NULL
B	NULL
gene	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
343	NULL
:	NULL
177-180	NULL
,	NULL
1990	NULL
.	NULL

57	NULL
.	NULL

Mader	NULL
,	NULL
S.	NULL
,	NULL
Chen	NULL
,	NULL
J-Y	NULL
.	NULL

,	NULL
Chen	NULL
,	NULL
Z.	NULL
,	NULL
White	NULL
,	NULL
J.	NULL
,	NULL
Chambon	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Gronemeyer	NULL
,	NULL
H.	NULL
The	NULL
pattern	NULL
of	NULL
binding	NULL
of	NULL
RAR	NULL
,	NULL
RXR	NULL
and	NULL
TR	NULL
homo-	NULL
and	NULL
heterodimers	NULL
to	NULL
direct	NULL
repeats	NULL
are	NULL
dictated	NULL
by	NULL
the	NULL
binding	NULL
specificities	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
domains	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
12	NULL
:	NULL
5029-5041	NULL
,	NULL
1993	NULL
.	NULL

58	NULL
.	NULL

Fan	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
Two	NULL
different	NULL
virus-inducible	NULL
elements	NULL
are	NULL
required	NULL
for	NULL
human	NULL
B-interferon	NULL
gene	NULL
regulation	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
8	NULL
:	NULL
101-110	NULL
,	NULL
1989	NULL
.	NULL

59	NULL
.	NULL

Tuohimaa	NULL
,	NULL
P.	NULL
,	NULL
Biduer	NULL
,	NULL
M.	NULL
,	NULL
Jaéskel	NULL
&	NULL
inen	NULL
,	NULL
T.	NULL
,	NULL
Itkonen	NULL
,	NULL
A.	NULL
,	NULL
Lindfors	NULL
,	NULL
M.	NULL
,	NULL
Mahonen	NULL
,	NULL
A.	NULL
,	NULL
Palvimo	NULL
,	NULL
J.	NULL
,	NULL
Vilja	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
M	NULL
&	NULL
enp	NULL
#	NULL
4	NULL
,	NULL
P.	NULL
H.	NULL
Characterization	NULL
of	NULL
human	NULL
1,25-dihydroxyvitamin	NULL
D3	NULL
receptor	NULL
anti-peptide	NULL
antibodies	NULL
.	NULL

J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
43	NULL
:	NULL
649-657	NULL
,	NULL
1992	NULL
.	NULL

60	NULL
.	NULL

Rochette-Egly	NULL
,	NULL
C.	NULL
,	NULL
Gaub	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Lutz	NULL
,	NULL
Y.	NULL
,	NULL
Ali	NULL
,	NULL
S.	NULL
,	NULL
Scheuer	NULL
,	NULL
1.	NULL
,	NULL
and	NULL
Chambon	NULL
,	NULL
P.	NULL
Retinoic	NULL
acid	NULL
receptor-	NULL
:	NULL
immunodetection	NULL
and	NULL
phosphorylation	NULL
on	NULL
tyrosine	NULL
residues	NULL
.	NULL

Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

,	NULL
6	NULL
:	NULL
2197-2209	NULL
,	NULL
1992	NULL
.	NULL

61	NULL
.	NULL

Janknecht	NULL
,	NULL
R.	NULL
,	NULL
Emst	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
and	NULL
Nordheim	NULL
,	NULL
A.	NULL
SAP1a	NULL
is	NULL
a	NULL
nuclear	NULL
target	NULL
of	NULL
signaling	NULL
cascades	NULL
involving	NULL
ERKs	NULL
.	NULL

Oncogene	NULL
,	NULL
10	NULL
:	NULL
1209-1216	NULL
,	NULL
1995	NULL
.	NULL

-	NULL
.	NULL

1249	NULL

